
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            ITK overexpression enhances T cell cytotoxicity against DLBCL through the TCR-Ca2+-Calcineurin-NFAT-IFN-γ pathway - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="AE532FBF8AF23153052FBF0023148822.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="scirep">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12371038/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Scientific Reports">
<meta name="citation_title" content="ITK overexpression enhances T cell cytotoxicity against DLBCL through the TCR-Ca2+-Calcineurin-NFAT-IFN-γ pathway">
<meta name="citation_author" content="Huifang Liu">
<meta name="citation_author_institution" content="Department of Laboratory, Henan Provincial People’s Hospital, Zhengzhou, 450003 China">
<meta name="citation_author" content="Mengyang Zhang">
<meta name="citation_author_institution" content="Department of Pathology, Henan Provincial People’s Hospital, Zhengzhou, 450003 China">
<meta name="citation_author" content="Xianguang Zhu">
<meta name="citation_author_institution" content="Department of Laboratory, Henan Provincial People’s Hospital, Zhengzhou, 450003 China">
<meta name="citation_author" content="Guanghui Chen">
<meta name="citation_author_institution" content="Department of Laboratory, Henan Provincial People’s Hospital, Zhengzhou, 450003 China">
<meta name="citation_publication_date" content="2025 Aug 21">
<meta name="citation_volume" content="15">
<meta name="citation_firstpage" content="30789">
<meta name="citation_doi" content="10.1038/s41598-025-16112-3">
<meta name="citation_pmid" content="40841435">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12371038/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12371038/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12371038/pdf/41598_2025_Article_16112.pdf">
<meta name="description" content="Diffuse Large B-Cell Lymphoma (DLBCL) is the most prevalent pathological subtype of non-Hodgkin lymphoma (NHL). Patients with DLBCL often experience extremely poor prognoses due to drug resistance or relapse, and the limitations of existing ...">
<meta name="og:title" content="ITK overexpression enhances T cell cytotoxicity against DLBCL through the TCR-Ca2+-Calcineurin-NFAT-IFN-γ pathway">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Diffuse Large B-Cell Lymphoma (DLBCL) is the most prevalent pathological subtype of non-Hodgkin lymphoma (NHL). Patients with DLBCL often experience extremely poor prognoses due to drug resistance or relapse, and the limitations of existing ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12371038/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12371038">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1038/s41598-025-16112-3"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/41598_2025_Article_16112.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12371038%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12371038/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12371038/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12371038/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-scirep.jpg" alt="Scientific Reports logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Scientific Reports" title="Link to Scientific Reports" shape="default" href="http://www.nature.com/srep" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Sci Rep</button></div>. 2025 Aug 21;15:30789. doi: <a href="https://doi.org/10.1038/s41598-025-16112-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1038/s41598-025-16112-3</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22Sci%20Rep%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sci%20Rep%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Sci%20Rep%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Sci%20Rep%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>
<em>ITK</em> overexpression enhances T cell cytotoxicity against DLBCL through the TCR-Ca<sup>2+</sup>-Calcineurin-NFAT-IFN-γ pathway</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Liu%20H%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Huifang Liu</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Huifang Liu</span></h3>
<div class="p">
<sup>1</sup>Department of Laboratory, Henan Provincial People’s Hospital, Zhengzhou, 450003 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Liu%20H%22%5BAuthor%5D" class="usa-link"><span class="name western">Huifang Liu</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Mengyang Zhang</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Mengyang Zhang</span></h3>
<div class="p">
<sup>2</sup>Department of Pathology, Henan Provincial People’s Hospital, Zhengzhou, 450003 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Mengyang Zhang</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhu%20X%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Xianguang Zhu</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Xianguang Zhu</span></h3>
<div class="p">
<sup>1</sup>Department of Laboratory, Henan Provincial People’s Hospital, Zhengzhou, 450003 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhu%20X%22%5BAuthor%5D" class="usa-link"><span class="name western">Xianguang Zhu</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chen%20G%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Guanghui Chen</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Guanghui Chen</span></h3>
<div class="p">
<sup>1</sup>Department of Laboratory, Henan Provincial People’s Hospital, Zhengzhou, 450003 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chen%20G%22%5BAuthor%5D" class="usa-link"><span class="name western">Guanghui Chen</span></a>
</div>
</div>
<sup>1,</sup><sup>✉</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="Aff1">
<sup>1</sup>Department of Laboratory, Henan Provincial People’s Hospital, Zhengzhou, 450003 China </div>
<div id="Aff2">
<sup>2</sup>Department of Pathology, Henan Provincial People’s Hospital, Zhengzhou, 450003 China </div>
<div class="author-notes p"><div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div></div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2025 Jun 5; Accepted 2025 Aug 13; Collection date 2025.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© The Author(s) 2025</div>
<p><strong>Open Access</strong> This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <a href="https://creativecommons.org/licenses/by-nc-nd/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by-nc-nd/4.0/</a>.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12371038  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40841435/" class="usa-link">40841435</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="Abs1"><h2>Abstract</h2>
<p id="Par1">Diffuse Large B-Cell Lymphoma (DLBCL) is the most prevalent pathological subtype of non-Hodgkin lymphoma (NHL). Patients with DLBCL often experience extremely poor prognoses due to drug resistance or relapse, and the limitations of existing treatment regimens are evident. This study focuses on the mechanistic role and clinical significance of interleukin-2-inducible T-cell kinase (ITK) in DLBCL. Through bioinformatics analysis, it was found that ITK, as a key molecule in the T Cell Receptor (TCR) signaling pathway, is significantly underexpressed in DLBCL. This underexpression is associated with a poorer overall survival (OS) of patients and exhibits a negative correlation with the expression of the immune checkpoint molecule Programmed Death Ligand 1 (PD-L1), suggesting its potential involvement in the regulation of T cell exhaustion. In vitro experiments demonstrated that overexpression of Itk significantly enhanced the immunological activity of mouse T lymphocytes (CTLL-2), activating the TCR-Ca<sup>2+</sup>-Calcineurin-NFAT-IFN-γ signaling pathway. This led to improved calcium ion responsiveness in T cells, increased calcineurin activity, and nuclear translocation of Nuclear Factor of Activated T Cells (NFAT). It also enhanced cytokine secretion levels and proliferative capacity of cytotoxic T lymphocytes (CD8<sup>+</sup> T cells), thereby driving an anti-tumor immune response. In a co-culture model, overexpression of <em>Itk</em> significantly augmented the killing effect of CTLL-2 cells on DLBCL, inducing apoptosis in DLBCL cells. Furthermore, T cells overexpressing <em>Itk</em> exhibited a synergistic effect when combined with Rituximab, significantly enhancing the inhibition of DLBCL cell proliferation. This provides a clinically feasible approach to address the challenge of drug resistance in DLBCL treatment. This study unveils the molecular mechanism by which ITK enhances anti-tumor immunity through remodeling the T cell receptor signaling pathway, offering new theoretical grounds for the development of T cell function-activating combined therapeutic strategies for DLBCL.</p>
<section id="kwd-group1" lang="en" class="kwd-group"><p><strong>Keywords:</strong> Diffuse large B-cell lymphoma, ITK; TCR signaling pathway; Immune microenvironment; Rituximab</p></section><section id="kwd-group2" class="kwd-group"><p><strong>Subject terms:</strong> Cancer, Cell biology</p></section></section><section id="Sec1"><h2 class="pmc_sec_title">Introduction</h2>
<p id="Par29">Diffuse Large B-Cell Lymphoma (DLBCL) is the most prevalent aggressive subtype of non-Hodgkin lymphoma (NHL)<sup><a href="#CR1" class="usa-link" aria-describedby="CR1">1</a></sup>. Although the R-CHOP regimen (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone) has significantly improved patient survival rates, 30–40% of patients still experience extremely poor prognosis due to drug resistance or relapse, with a 5-year overall survival (OS) rate of less than 50%<sup><a href="#CR2" class="usa-link" aria-describedby="CR2">2</a>–<a href="#CR6" class="usa-link" aria-describedby="CR6">6</a></sup>. This heterogeneity is partly attributed to the complexity of the tumor microenvironment (TME)<sup><a href="#CR7" class="usa-link" aria-describedby="CR7">7</a>–<a href="#CR10" class="usa-link" aria-describedby="CR10">10</a></sup>, where T cell dysfunction is considered a core mechanism of immune evasion<sup><a href="#CR11" class="usa-link" aria-describedby="CR11">11</a>–<a href="#CR13" class="usa-link" aria-describedby="CR13">13</a></sup>. In recent years, T cell-activating immunotherapies, such as chimeric antigen receptor T-cell immunotherapy (CAR-T), have demonstrated therapeutic potential in relapsed or refractory DLBCL; however, their efficacy is limited by issues such as T cell exhaustion and antigen escape<sup><a href="#CR14" class="usa-link" aria-describedby="CR14">14</a>,<a href="#CR15" class="usa-link" aria-describedby="CR15">15</a></sup>. There is an urgent need to explore new molecular targets to optimize existing treatment strategies<sup><a href="#CR16" class="usa-link" aria-describedby="CR16">16</a></sup>.</p>
<p id="Par30">The T cell receptor (TCR) signaling pathway plays a central role in anti-tumor immune responses, and its downstream molecule, ITK, is a key regulator of calcium ion signaling, T cell activation, and cytokine secretion<sup><a href="#CR17" class="usa-link" aria-describedby="CR17">17</a></sup>. In the TCR signaling pathway, after TCR binds to the major histocompatibility complex (MHC)-antigen complex<sup><a href="#CR18" class="usa-link" aria-describedby="CR18">18</a></sup>, it activates lymphocyte-specific protein tyrosine kinase (LCK), Fyn protein tyrosine kinase, and other kinases, leading to the phosphorylation of the protein complex CD3 molecules and immunoreceptor tyrosine-based activation motifs (ITAMs), and activating ZAP70 kinase<sup><a href="#CR19" class="usa-link" aria-describedby="CR19">19</a></sup>. ZAP70 further phosphorylates downstream substrates, recruits various signaling molecules, and triggers a series of reactions, such as the activation of Rho family guanosine triphosphate (GTP) enzymes by the guanine nucleotide exchange factor (GEF) VAV, the activation of the Ras-MAPK pathway by growth factor receptor-bound protein 2 (GRB2) activating Ras, and the hydrolysis of PIP<sub>2</sub> by PLC-γ1 to generate DAG and IP<sub>3</sub>. IP<sub>3</sub> promotes the release of Ca<sup>2+</sup> from the endoplasmic reticulum<sup><a href="#CR20" class="usa-link" aria-describedby="CR20">20</a></sup>. Ca<sup>2+</sup> activates calcineurin (CaN), which dephosphorylates NFAT and translocates it to the cell nucleus, regulating the transcription of cytokines such as IFN-γ<sup><a href="#CR21" class="usa-link" aria-describedby="CR21">21</a></sup>. Meanwhile, previous studies have suggested that low ITK expression in the TME may be associated with T cell exhaustion, but its specific mechanism in DLBCL remains unclear<sup><a href="#CR22" class="usa-link" aria-describedby="CR22">22</a></sup>. Additionally, while Rituximab exhibits anti-tumor effects, its efficacy is limited by the functional suppression of effector cells, such as CD8<sup>+</sup> T cells and NK cells<sup><a href="#CR23" class="usa-link" aria-describedby="CR23">23</a>–<a href="#CR25" class="usa-link" aria-describedby="CR25">25</a></sup>. Therefore, it is of great significance to elucidate how ITK reshapes the immune microenvironment through the TCR signaling pathway<sup><a href="#CR26" class="usa-link" aria-describedby="CR26">26</a></sup>, and to explore its synergistic effects with existing therapies<sup><a href="#CR27" class="usa-link" aria-describedby="CR27">27</a>–<a href="#CR30" class="usa-link" aria-describedby="CR30">30</a></sup>.</p>
<p id="Par31">This study systematically investigates the mechanistic role of ITK in DLBCL based on bioinformatics analysis and functional experiments. Initially, through transcriptome data mining, we found that ITK is significantly underexpressed in DLBCL and is associated with poor patient prognosis and an immunosuppressive microenvironment. Subsequently, using cell models, we verified that <em>ITK</em> overexpression promotes IFN-γ secretion by enhancing the TCR-Ca<sup>2+</sup>-Calcineurin-NFAT signaling pathway and enhances the function of CD8<sup>+</sup> T cells. Finally, through co-culture models and drug synergistic experiments, we confirmed that <em>ITK</em> overexpression exhibits a synergistic effect with rituximab. This study aims to elucidate the molecular mechanism by which ITK regulates the immune microenvironment in DLBCL and to provide a theoretical basis for the development of combined treatment strategies centered on T cell function remodeling.</p></section><section id="Sec2"><h2 class="pmc_sec_title">Materials and methods</h2>
<section id="Sec3"><h3 class="pmc_sec_title">Bioinformatics analysis</h3>
<p id="Par32">In this study, the <a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE32018" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">GSE32018</a> dataset was retrieved from the GEO database (<a href="https://www.ncbi.nlm.nih.gov/geo/" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.ncbi.nlm.nih.gov/geo/</a>), which includes a total of 114 B-cell non-Hodgkin lymphoma (B-NHL) samples, of which 22 are DLBCL samples. Additionally, the dataset contains 13 healthy control samples, consisting of 7 normal fresh-frozen lymph node samples and 6 normal fresh-frozen reactive tonsil samples. Differentially expressed genes (DEGs) were analyzed using the R package Limma (adjusted threshold <em>p</em> &lt; 0.05, |Log<sub>2</sub> Foldchange|&gt; 2). Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses of DEGs were performed using Metascape (<a href="https://metascape.org/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://metascape.org/</a>). The correlation between ITK expression and prognostic survival in patients receiving immunotherapy was assessed using Kaplan–Meier Plotter (<a href="https://kmplot.com/analysis/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://kmplot.com/analysis/</a>). The correlation between ITK expression and tumor purity as well as immune cell infiltration was analyzed using Timer2.0. To further explore the function of ITK in DLBCL, a CD8<sup>2+</sup> T cell-specific ITK network module in DLBCL, containing 41 genes, was obtained from the CellNetdb database (<a href="http://www.bioailab.com:3838/CellNetdb/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://www.bioailab.com:3838/CellNetdb/</a>). GO function and KEGG enrichment analyses of module genes were performed using the R package clusterProfiler. The R package GSVA was employed to calculate the ITK network module scores for the samples, utilizing the <a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE32918" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">GSE32918</a> dataset, which includes 172 DLBCL patients, 140 of whom were treated with R-CHOP and 32 who did not receive treatment with curative intent. Samples were divided into high and low ITK module score groups based on the median score. The prognostic value of module scores for patient survival was assessed using Kaplan–Meier survival analysis, ROC curves, and multivariate Cox regression. To investigate the transcriptional heterogeneity between high and low ITK module score groups, DEGs analysis was performed using limma (adjusted <em>p</em> &lt; 0.05, |Log<sub>2</sub> Foldchange|&gt; 2), and functional enrichment analysis of module DEGs was conducted. To reveal the inter-group heterogeneity of the tumor immune microenvironment, the R package CIBERSORT was used to calculate the proportion of immune cell infiltration. Immune cytolytic activity (CYT) was calculated using granzyme A (GzmA) and perforin 1 (PRF1). The association between ITK module scores and immunotherapy response was explored. Group comparisons were performed using the Wilcoxon rank-sum test (<em>p</em> &lt; 0.05 was considered statistically significant).</p></section><section id="Sec4"><h3 class="pmc_sec_title">Cell culture</h3>
<p id="Par33">The mouse cytotoxic T lymphocyte line CTLL-2 was purchased from the American Type Culture Collection (ATCC, USA, TIB-214), and the mouse B-cell lymphoma cell line A20 was purchased from ATCC (USA, TIB-208). CTLL-2 cells were cultured in RPMI 1640 medium (Gibco, USA, 11875093) supplemented with 10% fetal bovine serum (FBS, Gibco, 10099141), 100 U/ml recombinant mouse IL-2 (PeproTech, USA, 212–12), and 1% penicillin–streptomycin (Gibco, USA, 15140122). A20 cells were cultured in RPMI 1640 medium supplemented with 10% FBS. All cells were maintained in a humidified incubator at 37 °C with 5% CO<sub>2</sub> and were passaged every 2–3 days. Cells were continuously grown in the logarithmic growth phase to maintain good cell viability.</p></section><section id="Sec5"><h3 class="pmc_sec_title">ITK overexpression and knockdown</h3>
<p id="Par34">For <em>Itk</em> overexpression, the full-length cDNA of mouse <em>Itk</em> (GenBank: <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_001081143.1" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_001081143.1</a>) was cloned into the lentiviral vector pLVX-IRES-Puro (Clontech, USA, 632,183). Prior to transfection, HEK293T cells were seeded in 6-well plates and transfected when the cell confluence reached 70–80%. The above vector was co-transfected with packaging plasmids (psPAX2, pMD2.G) into HEK293T cells (ATCC, USA, CRL-3216). Viral supernatants were collected 48–72 h post-transfection and used to infect CTLL-2 cells in the logarithmic growth phase. During infection, polybrene (8 μg/ml, Sigma, USA, TR-1003) was added to facilitate viral infection. Stable <em>ITK</em>-overexpressing cell lines were selected using puromycin (2 μg/mL, Gibco, USA, A1113803) for 2–3 weeks until stable cell lines were obtained.</p>
<p id="Par35">To construct the <em>Itk</em> knockdown vector, three shRNAs targeting the <em>Itk</em> mRNA sequence (shRNA-1: 5′-GCAAGATGTACTTCAAGAT-3′; shRNA-2: 5′-GCCTGTAATGTGCTCATTA-3′) were designed and cloned into the pLKO.1 vector (Addgene, USA, 10,878). A scrambled vector (pLKO.1-scramble) was used as a negative control. Prior to transfection, CTLL-2 cells were seeded in 24-well plates and transfected when the cell confluence reached 70–80%. Lipofectamine RNAiMAX (Thermo Fisher Scientific, USA, 13,778,150) transfection reagent was used. Cells were collected 48 h post-transfection, and the mRNA and protein expression levels of <em>Itk</em> were detected by qPCR and Western Blot to confirm the knockdown effect.</p></section><section id="Sec6"><h3 class="pmc_sec_title">qRT-PCR analysis</h3>
<p id="Par36">Total RNA was extracted using Trizol reagent (Thermo Fisher Scientific, USA, A33252), and RNA concentration and purity were detected using a Nanodrop 2000. cDNA was synthesized using the Revert Aid First Strand cDNA Synthesis Kit (Thermo Fisher Scientific, USA, K1622). qRT-PCR analysis was performed using the SYBR Green Supermix Kit (Thermo Fisher Scientific, USA, 11,762,100). The primer sequences are shown in Table <a href="#Tab1" class="usa-link">1</a>. A 20 μl reaction system was prepared in a 96-well plate, including 10 μL SYBR Green Supermix, 0.5 μL each of the forward and reverse primers (10 μM, primers were PAGE-purified to ensure purity), 2 μL cDNA template, and 7 μL ddH<sub>2</sub>O. The reaction conditions were as follows: 95 °C for 30 s for pre-denaturation, followed by 40 cycles of 95 °C for 5 s for denaturation and 60 °C for 30 s for annealing and extension. Melt curve analysis was also performed to verify the specificity of the amplification products. Each sample was analyzed in three biological replicates, with β-actin used as an internal reference gene. The relative expression levels of target genes were calculated using the 2<sup>−ΔΔCt</sup> method.</p>
<section class="tw xbox font-sm" id="Tab1"><h4 class="obj_head">Table 1.</h4>
<div class="caption p"><p>Primer sequence.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1">Species</th>
<th align="left" colspan="1" rowspan="1">Primer name</th>
<th align="left" colspan="1" rowspan="1">Amplicon size</th>
<th align="left" colspan="1" rowspan="1">F/R</th>
<th align="left" colspan="1" rowspan="1">Sequence 5’-3’</th>
<th align="left" colspan="1" rowspan="1">Length</th>
<th align="left" colspan="1" rowspan="1">Location</th>
</tr></thead>
<tbody>
<tr>
<td align="left" rowspan="6" colspan="1">Mus musculus</td>
<td align="left" rowspan="2" colspan="1"><em>Itk</em></td>
<td align="left" rowspan="2" colspan="1">116</td>
<td align="left" colspan="1" rowspan="1">Forward</td>
<td align="left" colspan="1" rowspan="1">GGAAGAAGCGCACGTTGAAG</td>
<td align="left" colspan="1" rowspan="1">20</td>
<td align="center" colspan="1" rowspan="1">137–156</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Reverse</td>
<td align="left" colspan="1" rowspan="1">ATGCACGACCTGAAAAGGGTA</td>
<td align="left" colspan="1" rowspan="1">21</td>
<td align="center" colspan="1" rowspan="1">252–232</td>
</tr>
<tr>
<td align="left" rowspan="2" colspan="1">TNF-α</td>
<td align="left" rowspan="2" colspan="1">127</td>
<td align="left" colspan="1" rowspan="1">Forward</td>
<td align="left" colspan="1" rowspan="1">GAAAAGCAAGCAGCCAACCA</td>
<td align="left" colspan="1" rowspan="1">20</td>
<td align="center" colspan="1" rowspan="1">85–104</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Reverse</td>
<td align="left" colspan="1" rowspan="1">TCTTCTGCCAGTTCCACGTC</td>
<td align="left" colspan="1" rowspan="1">20</td>
<td align="center" colspan="1" rowspan="1">211–192</td>
</tr>
<tr>
<td align="left" rowspan="2" colspan="1">CD69</td>
<td align="left" rowspan="2" colspan="1">102</td>
<td align="left" colspan="1" rowspan="1">Forward</td>
<td align="left" colspan="1" rowspan="1">CCCTTGGGCTGTGTTAATAGTG</td>
<td align="left" colspan="1" rowspan="1">22</td>
<td align="center" colspan="1" rowspan="1">123–144</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Reverse</td>
<td align="left" colspan="1" rowspan="1">AACTTCTCGTACAAGCCTGGG</td>
<td align="left" colspan="1" rowspan="1">21</td>
<td align="center" colspan="1" rowspan="1">224–204</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section></section><section id="Sec7"><h3 class="pmc_sec_title">ELISA</h3>
<p id="Par37">ELISA kits (R&amp;D Systems, USA, DY485 for IFN-γ detection and DY410 for TNF-α detection) were used to measure the concentrations of IFN-γ and TNF-α in cell culture supernatants. Ninety-six-well ELISA plates were coated with the corresponding capture antibodies and incubated overnight at 4 °C. The next day, the coating solution was discarded, and the plates were washed three times with washing buffer (provided in the kit) for 3 min each time. Blocking buffer (provided in the kit) was added, and the plates were incubated at room temperature for 1 h. After discarding the blocking buffer and washing three times, cell culture supernatants were added (with three biological replicates for each sample), and the plates were incubated at room temperature for 2 h. Following three washes, biotinylated detection antibodies were added and incubated at room temperature for 1 h. After three washes, avidin-HRP was added and incubated at room temperature for 30 min. After three washes, TMB substrate solution was added, and the color was developed in the dark for 15–30 min. Stop solution (provided in the kit) was added to terminate the reaction, and the absorbance at 450 nm was read on a microplate reader (BioTek, Synergy H1). The kit provided standard substances, which were diluted and used to plot standard curves according to the instructions. The cytokine concentrations were calculated based on the standard curves.</p></section><section id="Sec8"><h3 class="pmc_sec_title">Western blot</h3>
<p id="Par38">Cells were collected and lysed on ice for 30 min with RIPA lysis buffer (Beyotime, China, P0013B) containing protease inhibitors (Roche, Switzerland, 04,693,132,001) and phosphatase inhibitors (Thermo Fisher Scientific, USA, 78,420). The lysates were centrifuged at 12,000 rpm and 4 °C for 15 min to obtain total proteins. The protein concentrations were measured using a BCA protein quantification kit (Thermo Fisher Scientific, USA, 23,225). After adjusting the protein concentrations, 5 × SDS loading buffer (Beyotime, China, P0015L) was added, and the samples were boiled at 100 °C for denaturation. SDS-PAGE gels of appropriate concentrations (using a Tris–HCl buffer system) were prepared for electrophoresis to separate the proteins. The proteins were then transferred to PVDF membranes (Millipore, USA, IPVH00010). The membranes were blocked with 5% non-fat milk (BD, USA, 232,100) in TBST buffer (20 mM Tris–HCl, 150 mM NaCl, 0.1% Tween 20, pH 7.6) for 1–2 h. The membranes were incubated overnight at 4 °C with rabbit anti-mouse ITK antibody (Cell Signaling Technology, USA, #3769) diluted 1:1000 and rabbit anti-mouse β-actin antibody (Cell Signaling Technology, USA, #4970) diluted 1:2000. HRP-labeled goat anti-rabbit secondary antibody (Cell Signaling Technology, USA, #7074) diluted 1:5000 was added and incubated at room temperature for 1–2 h. After washing with TBST, the membranes were developed using a chemiluminescent substrate (Thermo Fisher Scientific, USA, 34,580) and exposed on a chemiluminescent imaging system (Bio-Rad, USA, ChemiDoc MP). The band gray values were analyzed using ImageJ software. The relative expression of ITK was calculated using β-actin as an internal reference to analyze the differences in ITK protein expression among different treatment groups.</p></section><section id="Sec9"><h3 class="pmc_sec_title">Immunofluorescence assay</h3>
<p id="Par39">Cells were collected and digested into a single-cell suspension using 0.25% trypsin–EDTA (Gibco, USA, 25,200,072). The cell density was adjusted to 1 × 10<sup>5</sup> cells/mL, and the cells were seeded on poly-L-lysine-coated slides (Thermo Fisher Scientific, USA, 15,040–010), cell slides were formed after 24 h of culture. The cells were fixed with 4% paraformaldehyde (Sigma, USA, P6148), permeabilized with 0.1% Triton X-100 (Sigma, USA, T8787), and blocked with 5% bovine serum albumin (BSA, Sigma, USA, A9647). Diluted anti-NFATc1 antibody (Cell Signaling, USA, #8032, 1:200) was added and incubated overnight at 4 °C. The next day, after washing with PBS (Gibco, USA, 10,010,023), Alexa Fluor 488-labeled goat anti-rabbit secondary antibody (Invitrogen, USA, A-11008, 1:500) was added and incubated at room temperature in the dark. After washing with PBS, the cell nuclei were stained with 4’,6-diamidino-2-phenylindole (DAPI, Sigma, USA, D9542, 1 μg/mL). Finally, the slides were mounted with fluorescence mounting medium (Vector Laboratories, USA, H-1000) and observed under a confocal microscope (Zeiss LSM 880). The fluorescence intensity differences were analyzed using ImageJ software.</p></section><section id="Sec10"><h3 class="pmc_sec_title">Dynamic monitoring of calcium ions</h3>
<p id="Par40">CTLL-2 cells were seeded in confocal dishes (Ibidi, Germany, 81,218–200) at a density of 1 × 10<sup>5</sup> cells per dish 24 h before the experiment to allow cell attachment. On the day of the experiment, the cells were washed twice with PBS and incubated with Fluo-4 AM (Thermo Fisher Scientific, USA, <a href="https://www.ncbi.nlm.nih.gov/nuccore/F14201" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">F14201</a>)-containing serum-free RPMI-1640 medium at a concentration of 5 μM at 37 °C for 30 min to allow sufficient entry of Fluo-4 AM into the cells. After incubation, the cells were washed three times with PBS to remove unincorporated Fluo-4 AM. The Fluo-4 AM-loaded CTLL-2 cells were placed in a culture medium containing anti-CD3/CD28 magnetic beads (Thermo Fisher Scientific, USA, 11452D) (with a bead-to-cell ratio of 1:1) and observed under a fluorescence microscope. Fluorescence signals were captured every 10 s for 5 min. The peak calcium ion intensity was analyzed using ImageJ software.</p></section><section id="Sec11"><h3 class="pmc_sec_title">Calcineurin phosphatase activity assay</h3>
<p id="Par41">Calcineurin phosphatase activity was measured using a Calcineurin phosphatase activity assay kit (Abcam, USA, ab138910). The cells were washed twice with pre-cooled PBS, collected into centrifuge tubes, and lysed on ice for 30 min with an appropriate amount of cell lysis buffer (provided in the kit), with occasional vortexing during the process. After lysis, the samples were centrifuged at 12,000 rpm and 4 °C for 15 min, and the supernatants were collected as cell lysates. According to the kit instructions, the reaction was carried out in a 96-well plate. Fifty μL of cell lysate was added to each reaction well, followed by 50 μL of reaction buffer (provided in the kit) and 50 μL of substrate solution (provided in the kit), and gently mixed. The 96-well plate was placed in a microplate reader and incubated at 37 °C for 30 min, with the absorbance at 405 nm read every 5 min. Calcineurin phosphatase activity was expressed as the amount of substrate hydrolysis per unit time (calculated based on the absorbance change) using the following formula: Calcineurin phosphatase activity = (A405 final-405 initial)/reaction time (minutes) × dilution factor, where A405 final and A405 initial are the absorbance values at 405 nm at the end and start of the reaction, respectively.</p></section><section id="Sec12"><h3 class="pmc_sec_title">TCR activation experiment</h3>
<p id="Par42">Anti-mouse CD3 antibody (BioLegend, USA, 100,302, 1 μg/mL) and anti-mouse CD28 antibody (BioLegend, USA, 102,102, 1 μg/mL) were mixed at a 1:1 ratio and added to a centrifuge tube containing Dynabeads™ M-450 magnetic beads (Thermo Fisher Scientific, USA, 14013D) to achieve a final bead concentration of 1 × 10⁷/mL. The mixture was incubated at 37 °C for 2 h, with gentle vortexing every 20 min to ensure sufficient binding of the antibodies to the beads. After incubation, the beads were washed three times with PBS. During each wash, the beads were placed on a magnetic stand, the supernatant was discarded, and fresh PBS was added to resuspend the beads to remove unbound antibodies. CTLL-2 cells were adjusted to a density of 1 × 10<sup>6</sup>/mL and added to a 24-well plate at a bead-to-cell ratio of 1:1, with a volume of 1 mL per well. The plate was co-incubated for 24 h at 37 °C in a 5% CO<sub>2</sub> incubator to ensure an appropriate growth environment for the cells. After incubation, the cells were collected for subsequent analysis to investigate the cellular responses after TCR activation.</p></section><section id="Sec13"><h3 class="pmc_sec_title">Co-culture model of A20 cells and CTLL-2 cells</h3>
<p id="Par43">Before the experiment, a 96-well plate was washed twice with sterile PBS and placed in a super clean bench to air-dry. A20 cells in the logarithmic growth phase were digested with 0.25% trypsin–EDTA, and the digestion was terminated with RPMI 1640 medium containing 10% FBS. The cells were collected by centrifugation at 1000 rpm for 5 min. The cells were resuspended in fresh medium, and the cell density was adjusted to 3 × 10<sup>3</sup> cells/mL. The cells were seeded in a 96-well plate at a volume of 100 μL per well and cultured in a 37 °C, 5% CO<sub>2</sub> incubator to allow cell attachment for 2–4 h. After A20 cell attachment, CTLL-2 cells were processed in the same way, and the cell density was adjusted to 1 × 10<sup>3</sup> cells/mL. One hundred μL of CTLL-2 cell suspension was added to each well of the 96-well plate already seeded with A20 cells for co-culture. The co-culture time was set to 24 h. During the co-culture period, the cell state was closely monitored to ensure a stable culture environment and avoid contamination.</p></section><section id="Sec14"><h3 class="pmc_sec_title">Cell viability assay</h3>
<p id="Par44">After 24 h of co-culture, 10 μL of CCK-8 reagent (Dojindo, USA, CK04) was added to each well and gently mixed to avoid bubbles. The 96-well plate was placed in a 37 °C, 5% CO<sub>2</sub> incubator and incubated for another 2 h. After incubation, the 96-well plate was taken out of the incubator and placed on a microplate reader to measure the absorbance at 450 nm. The cell viability was calculated as follows: Cell viability (%) = (number of viable cells/total number of cells) × 100%. Each experimental condition had six biological replicates, and the average values were used for statistical analysis to reduce experimental errors.</p></section><section id="Sec15"><h3 class="pmc_sec_title">Apoptosis assay</h3>
<p id="Par45">Apoptosis was detected using a TUNEL kit (Roche, USA, 11,684,795,910). The co-cultured cells were gently washed twice with PBS for 5 min each time. The cells were fixed with 4% paraformaldehyde at room temperature for 30 min and then washed three times with PBS for 5 min each time. The cells were permeabilized with 0.1% Triton X-100 at room temperature for 10 min and then washed three times with PBS for 5 min each time. 50 μL of TUNEL reaction mixture (prepared according to the kit instructions) was added to each well and gently mixed to avoid bubbles. The 96-well plate was placed in a wet box and incubated at 37 °C in the dark for 60 min. After incubation, the cells were washed three times with PBS for 5 min each time. 50 μL of DAPI staining solution was added to each well and incubated at room temperature in the dark for 5 min to stain the cell nuclei. The cells were washed three times with PBS for 5 min each time. The cells were observed under a fluorescence microscope, with TUNEL-positive cells (green fluorescence) observed at a wavelength of 488 nm and DAPI-stained cell nuclei (blue fluorescence) observed at a wavelength of 358 nm. Each group had six biological replicates. The cells were observed under a fluorescence microscope, and the fluorescence intensity was analyzed using ImageJ software.</p></section><section id="Sec16"><h3 class="pmc_sec_title">Rituximab synergy experiment</h3>
<p id="Par46">A20 cells were seeded in a 96-well plate at a density of 3 × 10<sup>3</sup> cells per well. After cell attachment, different concentrations (0, 0.1, 1, 10 μg/mL) of rituximab (Roche, USA, 04,718,616,001) and CTLL-2 cells (1 × 10<sup>3</sup> cells per well) were added for co-culture. The co-culture time was 24 h. After co-culture, cell viability was measured using the CCK-8 method. According to the above cell viability assay method, the absorbance at 450 nm was measured on a microplate reader, and the cell viability of different treatment groups was calculated. Based on the cell viability data, reaction curves were plotted using GraphPad Prism 9.0 software, and the IC<sub>50</sub> value (half-maximal inhibitory concentration), which is the drug concentration required to inhibit 50% of cell growth, was calculated through non-linear regression analysis. Each concentration had six biological replicates, and the experiment was repeated three times to ensure the reliability and repeatability of the experimental results.</p></section><section id="Sec17"><h3 class="pmc_sec_title">Statistical analysis</h3>
<p id="Par47">All experimental data were presented as mean ± standard deviation (mean ± SD). SPSS 26.0 software (IBM Corporation) and GraphPad Prism 9.0 software were used for statistical analysis. First, normality tests (such as the Shapiro–Wilk test) were performed on the data. If the data followed a normal distribution, independent sample <em>t</em> tests were used for comparisons between two groups, and one-way analysis of variance (ANOVA) with Tukey’s test for multiple comparisons was used for more than two groups. If the data did not follow a normal distribution, non-parametric tests (such as the Kruskal–Wallis test) with Dunn’s test for multiple comparisons were used. The significance level was indicated as *<em>p</em> &lt; 0.05, **<em>p</em> &lt; 0.01, ***<em>p</em> &lt; 0.001, ****<em>p</em> &lt; 0.0001. <em>p</em> &lt; 0.05 was considered statistically significant, and ns = not significant.</p></section></section><section id="Sec18"><h2 class="pmc_sec_title">Results</h2>
<section id="Sec19"><h3 class="pmc_sec_title">Analysis of DEGs between DLBCL tissues and normal lymph node tissues and the correlation between ITK expression and prognosis of immune checkpoint therapy</h3>
<p id="Par48">The <a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE32018" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">GSE32018</a> dataset includes 114 B-NHL samples, of which 22 correspond to DLBCL. Focusing on the gene expression profiles associated with DLBCL, this study specifically selected the 22 DLBCL samples and compared them to 7 healthy lymph node samples, leading to the identification of 382 DEGs. Among these, 68 genes were upregulated and 314 genes were downregulated in DLBCL tissues compared to normal tissues. The results demonstrated that <em>ITK</em> was significantly underexpressed in DLBCL tissues (Fig. <a href="#Fig1" class="usa-link">1</a>a). KEGG pathway and GO functional enrichment analyses of the DEGs were conducted using Metascape (Fig. <a href="#Fig1" class="usa-link">1</a>b). The results indicated that the DEGs were mainly enriched in pathways and functions such as cytokine-cytokine receptor interaction, T cell receptor signaling pathway, adaptive immune response, and T cell-mediated immunity, suggesting that these pathways and functions may play crucial roles in the pathogenesis of DLBCL.</p>
<figure class="fig xbox font-sm" id="Fig1"><h4 class="obj_head">Fig. 1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12371038_41598_2025_16112_Fig1_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a68b/12371038/4e25dbd0b35c/41598_2025_16112_Fig1_HTML.jpg" loading="lazy" id="MO1" height="647" width="669" alt="Fig. 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Analysis of DEGs between DLBCL tissues and normal lymph node tissues and the correlation between ITK expression and prognosis of immune checkpoint therapy. (<strong>a</strong>) Volcano plot of DEGs between DLBCL tissues and normal lymph node tissues. (<strong>b</strong>) GO functional enrichment and KEGG pathway enrichment of DEGs.<sup><a href="#CR31" class="usa-link" aria-describedby="CR31">31</a>–<a href="#CR33" class="usa-link" aria-describedby="CR33">33</a></sup> GO enrichment includes biological processes (BP), cellular components (CC), and molecular functions (MF). (<strong>c</strong>) Impact of high and low ITK expression on the overall survival of patients treated with anti-CTLA-1. (<strong>d</strong>) Impact of high and low ITK expression on the overall survival of patients treated with anti-PD-1. (<strong>e</strong>) Impact of high and low ITK expression on the overall survival of patients treated with anti-PD-L1. f. Correlation between tumor purity (Purity), CD8<sup>+</sup> T cell, CD4<sup>+</sup> T cell, and regulatory T cell immune infiltration levels calculated by TIMER and ITK expression.</p></figcaption></figure><p id="Par49">The Kaplan–Meier Plotter online website was employed to analyze the prognostic impact of ITK expression specifically in DLBCL patients treated with immune checkpoint inhibitors. It was found that the overall survival (OS) of DLBCL patients in the high ITK-expression group was significantly better than that in the low ITK-expression group after receiving treatment with cytotoxic T lymphocyte-associated protein 4 (Tremelimumab, anti-CTLA-4), programmed cell death 1 antibody (Cemiplimab, anti-PD-1), or programmed cell death 1 ligand 1 inhibitor (Durvalumab, anti-PD-L1) (Fig. <a href="#Fig1" class="usa-link">1</a>c–e). TIMER 2.0 analysis revealed a significant negative correlation between ITK expression and tumor purity, while a positive correlation was observed between ITK expression and the infiltration levels of CD8<sup>+</sup> T cells, CD4<sup>+</sup> T cells, and regulatory T cells (Fig. <a href="#Fig1" class="usa-link">1</a>f). This suggests that ITK may be involved in regulating immune cell infiltration in the TME, thereby affecting treatment response.</p></section><section id="Sec20"><h3 class="pmc_sec_title">Construction and functional enrichment of the ITK network module in CD8<sup>+</sup> T cells</h3>
<p id="Par50">To investigate the function of ITK in CD8<sup>+</sup> T cells, this study obtained a CD8<sup>+</sup> T cell-specific ITK network module in DLBCL from the CellNetdb database (Fig. <a href="#Fig2" class="usa-link">2</a>a). GO functional enrichment analysis of the ITK network module showed (Fig. <a href="#Fig2" class="usa-link">2</a>b) that the module was mainly involved in multiple BP such as antigen receptor-mediated signaling pathways, T cell activation regulation, and thymic T cell selection. KEGG pathway analysis further revealed that the module network was significantly enriched in pathways including the T cell receptor signaling pathway, PD-L1 expression and PD-1 cancer checkpoint pathway, and natural killer cell-mediated cytotoxicity (Fig. <a href="#Fig2" class="usa-link">2</a>c).</p>
<figure class="fig xbox font-sm" id="Fig2"><h4 class="obj_head">Fig. 2.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12371038_41598_2025_16112_Fig2_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a68b/12371038/3d753f5ad5bc/41598_2025_16112_Fig2_HTML.jpg" loading="lazy" id="MO2" height="551" width="669" alt="Fig. 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Construction of the ITK network module in CD8<sup>+</sup> T cells and its correlation analysis with the survival of DLBCL patients. (<strong>a</strong>) CD8<sup>+</sup> T cell-specific ITK network module obtained from CellNetdb. The size of the dots represents the degree of the module. (<strong>b</strong>) GO (BP) functions enriched in the network module. The size of the dots represents the number of genes overlapping with the functions. (<strong>c</strong>) KEGG pathways enriched in the network module.<sup><a href="#CR31" class="usa-link" aria-describedby="CR31">31</a>–<a href="#CR33" class="usa-link" aria-describedby="CR33">33</a></sup> The size of the dots represents the number of genes overlapping with the pathways. (<strong>d</strong>) Scatter plot of ITK module scores in DLBCL samples, with samples arranged from low to high scores. (<strong>e</strong>) Kaplan–Meier survival curves of the high- and low-ITK-module-score groups. (<strong>f</strong>) ROC curve for predicting 3-year survival outcomes based on ITK module scores. (<strong>g</strong>) Forest plot of multivariate Cox proportional hazards regression analysis.</p></figcaption></figure></section><section id="Sec21"><h3 class="pmc_sec_title">Survival predictive value of the ITK network module score</h3>
<p id="Par51">To assess the overall activity of the ITK network module in patients, the <a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE32918" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">GSE32918</a> dataset (containing 172 DLBCL patients) was used. The ITK module score was calculated using the R package GSVA, and samples were divided into high- and low-module-score groups based on the median score (Fig. <a href="#Fig2" class="usa-link">2</a>d). Kaplan–Meier survival analysis demonstrated that DLBCL patients in the low-module-score group had a worse 3-year OS (Fig. <a href="#Fig2" class="usa-link">2</a>e). The ROC curve showed that the area under the curve (AUC) for predicting 1-3-year survival in DLBCL patients was 0.65, 0.64, and 0.63, respectively (Fig. <a href="#Fig2" class="usa-link">2</a>f), indicating that the ITK module score could accurately predict the 3-year survival outcome of patients. Further multivariate Cox proportional hazards regression analysis was conducted. The forest plot showed that the ITK module score was an independent protective factor for patient survival, independent of gender, age, and molecular subtype (Germinal Center B-cell, GCB/non-GCB) (HR = 0.374, <em>P</em> value = 0.016) (Fig. <a href="#Fig2" class="usa-link">2</a>g). This suggests that ITK may play a central regulatory role in the immunotherapy of DLBCL by participating in various BP.</p></section><section id="Sec22"><h3 class="pmc_sec_title">Transcriptional heterogeneity analysis of high- and low-ITK-module-score groups</h3>
<p id="Par52">DEGs analysis was performed on DLBCL patients in the high- and low-ITK-module-score groups (adjusted <em>p</em> value &lt; 0.05 and |log<sub>2</sub> FC|&gt; 1.5). A total of 405 DEGs were identified, including 33 upregulated genes and 372 downregulated genes (Fig. <a href="#Fig3" class="usa-link">3</a>a, b). GO functional enrichment analysis showed that the ITK-module-related genes were significantly enriched in functions such as T cell activation, immune synapse formation, and cytotoxic effects (Fig. <a href="#Fig3" class="usa-link">3</a>c). KEGG pathway enrichment analysis revealed that the genes were enriched in pathways such as the T cell receptor signaling pathway and cytotoxic molecule pathway (Fig. <a href="#Fig3" class="usa-link">3</a>d), suggesting that the activity of the ITK module may be closely related to T cell exhaustion.</p>
<figure class="fig xbox font-sm" id="Fig3"><h4 class="obj_head">Fig. 3.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12371038_41598_2025_16112_Fig3_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a68b/12371038/cb3a0bf6ced4/41598_2025_16112_Fig3_HTML.jpg" loading="lazy" id="MO3" height="500" width="668" alt="Fig. 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Transcriptional heterogeneity analysis and functional enrichment results of high- and low-ITK-module-score groups. (<strong>a</strong>) Volcano plot of high- and low-ITK-module-score groups. The genes labeled in the figure are the five genes with the highest/lowest log<sub>2</sub> (Foldchange). (<strong>b</strong>). Heatmap of DEGs in high- and low-ITK-module-score groups. The color of the heatmap represents the gene expression levels in samples. Higher expression is indicated by a deeper color (red for high expression, green for low expression). (<strong>c</strong>) GO (BP) enrichment results of DEGs. (<strong>d</strong>) KEGG pathway enrichment results of DEGs.<sup><a href="#CR31" class="usa-link" aria-describedby="CR31">31</a>–<a href="#CR33" class="usa-link" aria-describedby="CR33">33</a></sup>.</p></figcaption></figure></section><section id="Sec23"><h3 class="pmc_sec_title">Inter-group heterogeneity of the tumor immune microenvironment</h3>
<p id="Par53">CIBERSORT was used to analyze the infiltration of 22 types of immune cells. It was found that the proportion of memory B cells and plasma cells was significantly increased in the low-score group, while the proportion of CD8<sup>+</sup> T cells, follicular helper T cells (Tfh), and activated memory CD4<sup>+</sup> T cells was significantly decreased (Fig. <a href="#Fig4" class="usa-link">4</a>a, b). ITK module scores were positively correlated with CD8<sup>+</sup> T cell infiltration and negatively correlated with memory B cell infiltration (Fig. <a href="#Fig4" class="usa-link">4</a>c). CYT analysis was conducted using GZMA and PRF1. Patients were divided into immune-therapy-responsive and immune-therapy-non-responsive groups. The proportion of immune-therapy-responsive patients was significantly higher in the high-ITK-module-score group, and the ITK module scores of responsive patients were significantly higher than those of non-responsive patients (Fig. <a href="#Fig4" class="usa-link">4</a>d–e). Correlation analysis showed a positive correlation between ITK module scores and CYT values (R = 0.45) (Fig. <a href="#Fig4" class="usa-link">4</a>f), suggesting that ITK may enhance the immune-therapy response of patients by affecting CD8<sup>+</sup> T cell immune infiltration.</p>
<figure class="fig xbox font-sm" id="Fig4"><h4 class="obj_head">Fig. 4.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12371038_41598_2025_16112_Fig4_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a68b/12371038/c9abfa9434b0/41598_2025_16112_Fig4_HTML.jpg" loading="lazy" id="MO4" height="556" width="668" alt="Fig. 4"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Heterogeneity of the tumor immune microenvironment among groups in DLBCL and the correlation between ITK expression and response to immunotherapy. (<strong>a</strong>) Box plots of the distribution of the proportions of differential immune cells. (<strong>b</strong>) Heatmap showing the expression levels of differential immune cells (blue represents low levels, and red represents high levels). (<strong>c</strong>) Lollipop plot displaying the correlation between the ITK module score and the content of differential immune cells. (<strong>d</strong>) Bar chart illustrating the distribution of CYT scores in samples, with annotation information for the high and low ITK module score groups above. (<strong>e</strong>) Box plot depicting the distribution of ITK module scores between the immune-responsive and non-responsive groups. (<strong>f</strong>) Scatter plot showing the correlation between the ITK module score and the CYT score. *<em>p</em> &lt; 0.05, **<em>p</em> &lt; 0.01, ***<em>p</em> &lt; 0.001, ****<em>p</em> &lt; 0.0001.</p></figcaption></figure></section><section id="Sec24"><h3 class="pmc_sec_title">Overexpression of Itk activates the TCR signaling pathway and enhances T cell function</h3>
<p id="Par54">To investigate the regulatory role of ITK in the immune capacity of CTLL-2 cells, CTLL-2 cell models with <em>Itk</em> overexpression (<em>Itk</em> OE) and <em>Itk</em> knockdown (<em>Itk</em> KD) were constructed, using an empty vector group and a blank group as controls. To validate the successful construction of the model, we performed qPCR and Western blot analyses to assess the expression levels of <em>Itk</em> in the different experimental groups. The results demonstrated a significant increase in both mRNA and protein expression of <em>Itk</em> in the <em>Itk</em> OE group, while a substantial decrease in expression was observed in the <em>Itk</em> KD group, confirming the successful establishment of the gene overexpression and knockdown models (Fig. <a href="#MOESM1" class="usa-link">S1</a>a). The corresponding uncropped Western Blot membranes are shown in Fig. <a href="#MOESM1" class="usa-link">S2</a>a. Further investigation revealed that, compared with the blank group and the empty vector group, the mRNA expression levels of tumor necrosis factor-α (TNF-α), ITK, and cluster of differentiation 69 (CD69) were significantly downregulated in the <em>Itk</em> KD group and significantly upregulated in the <em>Itk</em> OE group (Fig. <a href="#Fig5" class="usa-link">5</a>a–c), indicating that <em>Itk</em> overexpression positively regulates the ability of CTLL-2 cells to secrete antitumor factors. The CCK-8 cell proliferation assay demonstrated that the cell proliferation capacity was significantly enhanced in the <em>Itk</em> OE group and significantly reduced in the <em>Itk</em> KD group (Fig. <a href="#Fig5" class="usa-link">5</a>d), suggesting a positive correlation between <em>Itk</em> expression levels and the proliferation capacity of CTLL-2 cells.</p>
<figure class="fig xbox font-sm" id="Fig5"><h4 class="obj_head">Fig. 5.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12371038_41598_2025_16112_Fig5_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a68b/12371038/657704d636e8/41598_2025_16112_Fig5_HTML.jpg" loading="lazy" id="MO5" height="601" width="669" alt="Fig. 5"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig5/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Effects of <em>Itk</em> on the immune capacity of CTLL-2 cells. (<strong>a</strong>–<strong>c</strong>) Changes in the mRNA expression levels of TNF-α, ITK, and CD69 in CTLL-2 cells with different <em>Itk</em> expression levels. (<strong>d</strong>) Detection of the proliferation capacity of CTLL-2 cells with different <em>Itk</em> expression levels. (<strong>e</strong>, <strong>f</strong>). Overexpression of the <em>Itk</em> gene increases the intracellular calcium ion concentration in CTLL-2 cells. Scale bar, 50 µm. The green fluorescence in Fig. 5e indicates Fluo-4 staining, reflecting intracellular calcium levels. (<strong>g</strong>) Overexpression of <em>Itk</em> promotes an increase in calcineurin activity. (<strong>h</strong>, <strong>i</strong>) Both TCR activation and <em>Itk</em> overexpression promote NFAT nuclear translocation. Scale bar, 100 µm. (<strong>j</strong>) Overexpression of <em>Itk</em> promotes an increase in IFN-γ concentrations. <em>n</em> = 6, **<em>p</em> &lt; 0.01, ***<em>p</em> &lt; 0.001, ****<em>p</em> &lt; 0.0001, two-tailed <em>t</em> test.</p></figcaption></figure><p id="Par55">Further investigation into the role of ITK in the TCR signaling pathway was conducted. CTLL-2 cells were co-incubated with anti-CD3/CD28 antibody-coated magnetic beads to simulate antigen presentation and activate the TCR in CTLL-2 cells. Compared to the untreated control group and the anti-IgG (negative control) group, the total level of the key signaling molecule PLCγ1 remained unchanged after Anti-CD3/CD28 treatment, while its phosphorylation level significantly increased, indicating successful TCR activation (Fig. <a href="#MOESM1" class="usa-link">S1</a>b). The corresponding uncropped Western Blot membranes are presented in Fig. <a href="#MOESM1" class="usa-link">S2</a>b and c. For the calcium ion flow monitoring experiment, the CTLL-2 cells were divided into the following four groups: untreated CTLL-2 cells as the control group (Control), TCR-activated CTLL-2 cells as the TCR activation group (TCR activation), TCR-activated CTLL-2 cells transfected with an empty vector as the empty vector group (Empty vector), and TCR-activated CTLL-2 cells with <em>Itk</em> overexpression as the <em>Itk</em> OE group. The experimental results revealed that <em>Itk</em> overexpression significantly enhanced the calcium signal intensity after TCR activation. The calcium ion concentration showed a clear dynamic change trend from 0 to 60 s, with a significantly higher calcium ion peak compared with the EV group and the TCR activation group (Fig. <a href="#Fig5" class="usa-link">5</a>e, f). Additionally, calcineurin (CaN) was continuously activated, and its activity assay showed a significant increase in the enzymatic reaction rate (Fig. <a href="#Fig5" class="usa-link">5</a>i), suggesting a positive regulatory role of ITK in the TCR signaling pathway. Immunofluorescence confocal microscopy observations indicated that the nuclear translocation efficiency of the transcription factor NFAT was significantly higher in the <em>Itk</em> OE group than in the EV group (Fig. <a href="#Fig5" class="usa-link">5</a>g, h), indicating that <em>Itk</em> overexpression significantly enhanced NFAT nuclear translocation after TCR activation, further supporting the positive regulatory role of ITK in the TCR signaling pathway. ELISA was further used to verify the changes in the secretion level of IFN-γ after TCR activation. The results showed that compared with the control group and the EV group, the IFN-γ concentration was significantly higher in the <em>Itk</em> OE group (Fig. <a href="#Fig5" class="usa-link">5</a>j), suggesting that <em>Itk</em> overexpression enhances the calcium signal-Calcineurin-NFAT pathway, activates NFAT nuclear translocation to drive IFN-γ gene transcription, and increases its secretion level through signal amplification by ITK.</p></section><section id="Sec25"><h3 class="pmc_sec_title">Overexpression of Itk enhances the killing effect of CTLL-2 cells on DLBCL cells and its synergistic effect with rituximab</h3>
<p id="Par56">Considering that the A20 cell line is a mouse-derived B cell lymphoma cell line with certain biological features resembling those of DLBCL, we established an in vitro model using this cell line in the present study to assess the impact of <em>Itk</em> overexpression in CTLL-2 cells on DLBCL. A20 cells were co-cultured with <em>Itk</em>-overexpressing CTLL-2 cells. The experimental groups included a blank control group with only A20 cells (A20), a co-culture group of A20 cells and CTLL-2 cells (A20 + CTLL-2), and a group of A20 cells and <em>Itk</em>-overexpressing CTLL-2 cells (A20 + <em>Itk</em> OE CTLL-2). The results showed that compared with the blank control group, the number of A20 cells was significantly reduced after 24 h of co-culture in the A20 + <em>Itk</em> OE CTLL-2 group (Fig. <a href="#Fig6" class="usa-link">6</a>a–c), indicating that <em>Itk</em> overexpression significantly reduced the survival rate of A20 cells in the CTLL-2 and A20 cell co-culture model. TUNEL apoptosis assay results further confirmed that <em>Itk</em>-overexpressing CTLL-2 cells could significantly induce apoptosis in A20 cells (Fig. <a href="#Fig6" class="usa-link">6</a>e, f). These results suggest that <em>Itk</em> overexpression enhances the killing and pro-apoptotic effects of CTLL-2 cells on A20 cells. In addition, in the synergistic experiment with rituximab, the cell survival rate was significantly lower in the A20 + <em>Itk</em> OE CTLL-2 + Rituximab group compared with the A20 + Rituximab group and the A20 + CTLL-2 + Rituximab group. The IC50 value was 179.8 μg/mL in the A20 + Rituximab group, 109.7 μg/mL in the A20 + CTLL-2 + Rituximab group, and 53.53 μg/mL in the A20 + <em>Itk</em> OE CTLL-2 + Rituximab group. A decrease in the IC50 concentration of rituximab was observed after the combined treatment, suggesting a synergistic killing effect of <em>Itk</em>-overexpressing CTLL-2 cells and rituximab on A20 cells (Fig. <a href="#Fig6" class="usa-link">6</a>d, g). The above results indicate that <em>Itk</em> overexpression not only enhances the killing ability of CTLL-2 cells against A20 cells but also has a synergistic effect when used in combination with rituximab, providing new potential strategies and theoretical bases for DLBCL immunotherapy.</p>
<figure class="fig xbox font-sm" id="Fig6"><h4 class="obj_head">Fig. 6.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12371038_41598_2025_16112_Fig6_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a68b/12371038/d73e4b648adf/41598_2025_16112_Fig6_HTML.jpg" loading="lazy" id="MO6" height="442" width="669" alt="Fig. 6"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig6/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Effects of <em>Itk</em>-overexpressing CTLL-2 cells on A20. (<strong>a</strong>) Schematic diagram of the direct co-culture model of CTLL-2 cells (<em>Itk</em> OE) and A20 mouse B-cell lymphoma cells. (<strong>b</strong>, <strong>c</strong>). Effects of <em>Itk</em> overexpression in CTLL-2 cells on the proliferation of A20 cells. Scale bar, 50 µm. (<strong>d</strong>, <strong>e</strong>). Effects of <em>Itk</em>-overexpressing CTLL-2 cells on the apoptosis of A20 cells. Scale bar, 50 µm. (<strong>f</strong>) Fitted curve of cell survival rates in the rituximab synergistic experiment. (<strong>g</strong>) Bar chart of cell survival rates in each group in the rituximab synergistic experiment. <em>n</em> = 6, **<em>p</em> &lt; 0.01, ***<em>p</em> &lt; 0.001, ****<em>p</em> &lt; 0.0001, two-tailed <em>t</em> test.</p></figcaption></figure></section></section><section id="Sec26"><h2 class="pmc_sec_title">Discussion</h2>
<p id="Par57">This study systematically elucidated the function of ITK in the TCR signaling pathway, revealing its molecular mechanism of enhancing the anti-tumor activity of CD8<sup>+</sup> T cells through the TCR-Ca<sup>2+</sup>-Calcineurin-NFAT-IFN-γ signaling pathway (Fig. <a href="#Fig7" class="usa-link">7</a>). It also proposed ITK as a potential target for improving immunotherapy in DLBCL. Below, we discuss the study’s findings in terms of mechanistic innovation, clinical translational significance, and research limitations, integrating our experimental results with existing literature.</p>
<figure class="fig xbox font-sm" id="Fig7"><h3 class="obj_head">Fig. 7.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12371038_41598_2025_16112_Fig7_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a68b/12371038/0c97900c42f9/41598_2025_16112_Fig7_HTML.jpg" loading="lazy" id="MO7" height="547" width="708" alt="Fig. 7"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig7/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Overexpression of <em>ITK</em> promotes TCR signaling pathway activation in CTLL-2 cells, inhibits DLBCL growth, and has a synergistic effect with traditional chemotherapeutic drugs.</p></figcaption></figure><p id="Par58">Our study found that overexpression of <em>Itk</em> significantly enhanced the calcium ion response capability of CTLL-2 cells, activated the Calcineurin-NFAT signaling pathway, and ultimately drove IFN-γ secretion. This result aligns with the TCR signaling cascade model proposed by Vincent Guichard et al. which suggests that ITK promotes IP<sub>3</sub> generation by phosphorylating PLCγ1, thereby mediating calcium ion release<sup><a href="#CR34" class="usa-link" aria-describedby="CR34">34</a>–<a href="#CR36" class="usa-link" aria-describedby="CR36">36</a></sup>. However, our study further revealed that ITK’s regulatory role extends beyond the initiation phase of calcium signaling; it can also enhance NFAT nuclear translocation by increasing Calcineurin activity, thus improving the function and proliferative capacity of CD8<sup>+</sup> T cells and enhancing their cytotoxic activity against lymphoma cells (Fig. <a href="#Fig7" class="usa-link">7</a>). This discovery supplements previous understanding of ITK’s function, unveiling its new role in the dynamic regulation of signal transduction.</p>
<p id="Par59">Bioinformatics analysis indicated that low ITK expression is closely associated with poor prognosis and an immunosuppressive microenvironment in DLBCL patients. Specifically, samples with low ITK expression exhibited reduced CD8<sup>+</sup> T cell infiltration and increased expression of immune checkpoint molecules such as PD-L1, suggesting that tumors may induce T cell exhaustion by inhibiting ITK to achieve immune evasion. This finding is consistent with Wang et al.'s research on T cell dysfunction in DLBCL<sup><a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>,<a href="#CR37" class="usa-link" aria-describedby="CR37">37</a>,<a href="#CR38" class="usa-link" aria-describedby="CR38">38</a></sup>. However, our study directly linked ITK deficiency with the upregulation of immune checkpoints, providing new insights for developing combination therapies targeting the TME.</p>
<p id="Par60">Our co-culture experiments demonstrated that CTLL-2 cells overexpressing <em>Itk</em> significantly inhibited A20 cell proliferation and induced apoptosis, and when combined with rituximab, the IC<sub>50</sub> value was significantly reduced. This synergistic effect may stem from two mechanisms: on one hand, ITK activates and upregulates CD16 expression, promoting the synergistic killing of tumors by NK cells and T cells<sup><a href="#CR39" class="usa-link" aria-describedby="CR39">39</a>–<a href="#CR41" class="usa-link" aria-describedby="CR41">41</a></sup>; on the other hand, cytokine-mediated immune activation, such as IFN-γ, enhances tumor antigen presentation by upregulating MHC-I expression, thereby amplifying the targeted effect of rituximab<sup><a href="#CR42" class="usa-link" aria-describedby="CR42">42</a></sup>. Based on this, the development of small-molecule ITK agonists or combination with immune checkpoint inhibitors (such as PD-1 blockers) may represent an effective strategy to overcome R-CHOP resistance.<sup><a href="#CR43" class="usa-link" aria-describedby="CR43">43</a></sup></p>
<p id="Par61">Despite revealing the critical role of ITK, our study has certain limitations. In terms of models, the experiments primarily utilized the mouse T cell lines (CTLL-2) and lymphoma cell lines (A20). Given the distinct genetic and immune backgrounds of these two cell lines, incorporating additional in vitro models in future research would enhance the generalizability and reliability of the findings. To further improve clinical applicability, validation experiments should also be conducted using patient-derived primary T cells and PDX models, which would help address the differences in immune microenvironments between mouse models and human DLBCL. Furthermore, the current study employed an effector-to-target (E:T) ratio of 1:3. Although this ratio is representative to some extent, presenting experimental results across a range of E:T ratios in future studies would further strengthen the persuasiveness of the data and the reliability of the conclusions.</p>
<p id="Par62">In terms of mechanistic depth, although we confirmed NFAT nuclear translocation, the regulatory role of ITK on other transcription factors (such as AP-1 or NF-κB) remains to be explored. Our study focused solely on NFAT nuclear translocation without delving into the interactions between ITK and other transcription factors or epigenetic regulatory factors (such as histone-modifying enzymes), which may influence the comprehensive remodeling of T cell function. In terms of clinical relevance, the bioinformatics analysis was based on public databases (such as <a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE32018" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">GSE32018</a>, <a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE32918" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">GSE32918</a>), lacking validation from independent clinical cohorts, particularly insufficient data on the direct correlation between ITK expression and response to rituximab treatment. The analysis of the immune microenvironment did not utilize single-cell technology to dissect the heterogeneity of cell subpopulations and dynamic temporal effects. Future research needs to further explore model expansion, mechanistic deepening, clinical translation, and strategy optimization to enhance our understanding.</p>
<p id="Par63">Future research can proceed in the following directions: first, screening highly selective ITK agonists and evaluating their efficacy and safety in preclinical models; second, combining single-cell sequencing technology to dissect the heterogeneity of T cell subpopulations regulated by ITK; third, exploring the synergistic effects of ITK with other immune regulatory pathways, such as the Stimulator of interferon genes (STING) pathway or the T cell costimulatory receptor pathway (Tumor necrosis factor receptor superfamily member 4, OX40), to open new avenues for DLBCL treatment.</p></section><section id="Sec27"><h2 class="pmc_sec_title">Conclusion</h2>
<p id="Par64">This study systematically elucidated the immune regulatory mechanism and clinical significance of ITK in DLBCL through bioinformatics analysis and functional experiments. ITK is underexpressed in DLBCL tissues, and its expression level is positively correlated with patients’ overall survival (OS) and negatively correlated with the infiltration degree of CD8<sup>+</sup> T cells and the expression of immune checkpoint molecules such as PD-L1. In vitro experiments clarified the molecular mechanism by which ITK enhances the anti-DLBCL activity of CD8<sup>+</sup> T cells through the TCR-Ca<sup>2+</sup>-Calcineurin-NFAT-IFN-γ signaling pathway and revealed its synergistic therapeutic potential with rituximab. These findings provide an important theoretical basis for developing combination therapies for DLBCL based on T cell function remodeling, holding significant translational medicine value.</p></section><section id="Sec28"><h2 class="pmc_sec_title">Supplementary Information</h2>
<section class="sm xbox font-sm" id="MOESM1"><div class="media p"><div class="caption">
<a href="/articles/instance/12371038/bin/41598_2025_16112_MOESM1_ESM.docx" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Information.</a><sup> (513.4KB, docx) </sup>
</div></div></section></section><section id="glossary1" class="glossary"><h2 class="pmc_sec_title">Abbreviations</h2>
<dl class="def-list">
<dt>DLBCL</dt>
<dd><p id="Par2">Diffuse large B-cell lymphoma</p></dd>
<dt>NHL</dt>
<dd><p id="Par3">Non-Hodgkin lymphoma</p></dd>
<dt>TME</dt>
<dd><p id="Par4">Tumor microenvironment</p></dd>
<dt>CAR-T</dt>
<dd><p id="Par5">Chimeric antigen receptor T-cell immunotherapy</p></dd>
<dt>DEGs</dt>
<dd><p id="Par6">Differentially expressed genes</p></dd>
<dt>GO</dt>
<dd><p id="Par7">Gene ontology</p></dd>
<dt>KEGG</dt>
<dd><p id="Par8">Kyoto encyclopedia of genes and genomes</p></dd>
<dt>CYT</dt>
<dd><p id="Par9">Immune cytolytic activity</p></dd>
<dt>GzmA</dt>
<dd><p id="Par10">Granzyme A</p></dd>
<dt>PRF</dt>
<dd><p id="Par11">1Perforin 1</p></dd>
<dt>BP</dt>
<dd><p id="Par12">Biological processes</p></dd>
<dt>CC</dt>
<dd><p id="Par13">Cellular components</p></dd>
<dt>MF</dt>
<dd><p id="Par14">Molecular functions</p></dd>
<dt>Tfh</dt>
<dd><p id="Par15">Follicular helper T cells</p></dd>
<dt>Itk OE</dt>
<dd><p id="Par16">Itk overexpression</p></dd>
<dt>Itk KD</dt>
<dd><p id="Par17">Itk knockdown</p></dd>
<dt>TNF-α</dt>
<dd><p id="Par18">Tumor necrosis factor-α</p></dd>
<dt>CD69</dt>
<dd><p id="Par19">Cluster of differentiation 69</p></dd>
<dt>MHC</dt>
<dd><p id="Par20">Major histocompatibility complex</p></dd>
<dt>LCK</dt>
<dd><p id="Par21">Lymphocyte-specific protein tyrosine kinase</p></dd>
<dt>ITAMs</dt>
<dd><p id="Par22">Immunoreceptor tyrosine-based activation motifs</p></dd>
<dt>GTP</dt>
<dd><p id="Par23">Guanosine triphosphate</p></dd>
<dt>GEF</dt>
<dd><p id="Par24">Guanine nucleotide exchange factor</p></dd>
<dt>GRB2</dt>
<dd><p id="Par25">Growth factor receptor-bound protein 2</p></dd>
<dt>ADCC</dt>
<dd><p id="Par26">Antibody-dependent cell-mediated cytotoxicity</p></dd>
<dt>STING</dt>
<dd><p id="Par27">Stimulator of interferon genes</p></dd>
<dt>B-NHL</dt>
<dd><p id="Par28">B-cell non-Hodgkin lymphoma</p></dd>
</dl></section><section id="notes1"><h2 class="pmc_sec_title">Author contributions</h2>
<p>Huifang Liu: Data curation, Software, Writing—original draft. Mengyang Zhang: Data curation, Methodology. Xianguang Zhu: Methodology. Guanghui Chen: Writing—review &amp; editing. All authors reviewed the manuscript.</p></section><section id="notes2"><h2 class="pmc_sec_title">Funding</h2>
<p>This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.</p></section><section id="notes3"><h2 class="pmc_sec_title">Data availability</h2>
<p>Data is provided within the manuscript or supplementary information files.</p></section><section id="notes4"><h2 class="pmc_sec_title">Declarations</h2>
<section id="FPar1"><h3 class="pmc_sec_title">Competing interests</h3>
<p id="Par65">The authors declare no competing interests.</p></section><section id="FPar2"><h3 class="pmc_sec_title">Ethical approval</h3>
<p id="Par66">Not applicable.</p></section></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="fn1">
<p><strong>Publisher’s note</strong></p>
<p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</div></div></section><section id="sec29"><h2 class="pmc_sec_title">Supplementary Information</h2>
<p>The online version contains supplementary material available at 10.1038/s41598-025-16112-3.</p></section><section id="Bib1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="Bib1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="CR1">
<span class="label">1.</span><cite>Tilly, H. et al. Polatuzumab vedotin in previously untreated diffuse large B-cell lymphoma. <em>N. Engl. J. Med.</em><strong>386</strong>, 351–363. 10.1056/NEJMoa2115304 (2022).
</cite> [<a href="https://doi.org/10.1056/NEJMoa2115304" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11702892/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34904799/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tilly,%20H.%20et%20al.%20Polatuzumab%20vedotin%20in%20previously%20untreated%20diffuse%20large%20B-cell%20lymphoma.%20N.%20Engl.%20J.%20Med.386,%20351%E2%80%93363.%2010.1056/NEJMoa2115304%20(2022)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR2">
<span class="label">2.</span><cite>Cao, G. et al. Two-stage CD8<sup>(+)</sup> CAR T-cell differentiation in patients with large B-cell lymphoma. <em>Nat. Commun.</em><strong>16</strong>, 4205. 10.1038/s41467-025-59298-w (2025).
</cite> [<a href="https://doi.org/10.1038/s41467-025-59298-w" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC12055983/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40328775/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cao,%20G.%20et%20al.%20Two-stage%20CD8(+)%20CAR%20T-cell%20differentiation%20in%20patients%20with%20large%20B-cell%20lymphoma.%20Nat.%20Commun.16,%204205.%2010.1038/s41467-025-59298-w%20(2025)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR3">
<span class="label">3.</span><cite>Sato, S., Tsunoda, S., Kamata, W., Togano, T. &amp; Tamai, Y. Real-world effectiveness and safety of rituximab and reduced-dose CHP with polatuzumab vedotin (pola-R-CHP) in patients aged &gt; 80 years with diffuse large B-cell lymphoma: A retrospective analysis. <em>Blood Res.</em><strong>60</strong>, 10. 10.1007/s44313-025-00059-5 (2025).
</cite> [<a href="https://doi.org/10.1007/s44313-025-00059-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11799502/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39907880/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sato,%20S.,%20Tsunoda,%20S.,%20Kamata,%20W.,%20Togano,%20T.%20&amp;%20Tamai,%20Y.%20Real-world%20effectiveness%20and%20safety%20of%20rituximab%20and%20reduced-dose%20CHP%20with%20polatuzumab%20vedotin%20(pola-R-CHP)%20in%20patients%20aged%20&gt;%2080%20years%20with%20diffuse%20large%20B-cell%20lymphoma:%20A%20retrospective%20analysis.%20Blood%20Res.60,%2010.%2010.1007/s44313-025-00059-5%20(2025)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR4">
<span class="label">4.</span><cite>Xu, Z. Z. et al. Combination of rituximab and mammalian target of rapamycin inhibitor everolimus (RAD001) in diffuse large B-cell lymphoma. <em>Leuk Lymphoma</em><strong>55</strong>, 1151–1157. 10.3109/10428194.2013.823492 (2014).
</cite> [<a href="https://doi.org/10.3109/10428194.2013.823492" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23841505/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Xu,%20Z.%20Z.%20et%20al.%20Combination%20of%20rituximab%20and%20mammalian%20target%20of%20rapamycin%20inhibitor%20everolimus%20(RAD001)%20in%20diffuse%20large%20B-cell%20lymphoma.%20Leuk%20Lymphoma55,%201151%E2%80%931157.%2010.3109/10428194.2013.823492%20(2014)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR5">
<span class="label">5.</span><cite>Nijland, M. et al. Atezolizumab consolidation in patients with high risk diffuse large B-cell lymphoma in complete remission after R-CHOP. <em>Blood Adv.</em>10.1182/bloodadvances.2024015226 (2025).
</cite> [<a href="https://doi.org/10.1182/bloodadvances.2024015226" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC12274673/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40249860/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Nijland,%20M.%20et%20al.%20Atezolizumab%20consolidation%20in%20patients%20with%20high%20risk%20diffuse%20large%20B-cell%20lymphoma%20in%20complete%20remission%20after%20R-CHOP.%20Blood%20Adv.10.1182/bloodadvances.2024015226%20(2025)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR6">
<span class="label">6.</span><cite>Zhao, P. et al. Efficacy and safety of polatuzumab vedotin plus rituximab, cyclophosphamide, doxorubicin and prednisone for previously untreated diffuse large B-cell lymphoma: A real-world, multi-center, retrospective cohort study. <em>Hematol. Oncol.</em><strong>43</strong>, e70017. 10.1002/hon.70017 (2025).
</cite> [<a href="https://doi.org/10.1002/hon.70017" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39641321/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhao,%20P.%20et%20al.%20Efficacy%20and%20safety%20of%20polatuzumab%20vedotin%20plus%20rituximab,%20cyclophosphamide,%20doxorubicin%20and%20prednisone%20for%20previously%20untreated%20diffuse%20large%20B-cell%20lymphoma:%20A%20real-world,%20multi-center,%20retrospective%20cohort%20study.%20Hematol.%20Oncol.43,%20e70017.%2010.1002/hon.70017%20(2025)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR7">
<span class="label">7.</span><cite>Lin, C., Xie, S., Wang, M., Yang, B. &amp; Shen, J. Angiogenesis-related gene signature for prognostic prediction and immune microenvironment characterization in diffuse large B-cell lymphoma. <em>Clin. Exp. Med.</em><strong>25</strong>, 108. 10.1007/s10238-025-01628-9 (2025).
</cite> [<a href="https://doi.org/10.1007/s10238-025-01628-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11978719/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40198448/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lin,%20C.,%20Xie,%20S.,%20Wang,%20M.,%20Yang,%20B.%20&amp;%20Shen,%20J.%20Angiogenesis-related%20gene%20signature%20for%20prognostic%20prediction%20and%20immune%20microenvironment%20characterization%20in%20diffuse%20large%20B-cell%20lymphoma.%20Clin.%20Exp.%20Med.25,%20108.%2010.1007/s10238-025-01628-9%20(2025)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR8">
<span class="label">8.</span><cite>Wang, Y. Q. et al. Practical microenvironment classification in diffuse large B cell lymphoma using digital pathology. <em>Cell Rep. Med.</em><strong>6</strong>, 102030. 10.1016/j.xcrm.2025.102030 (2025).
</cite> [<a href="https://doi.org/10.1016/j.xcrm.2025.102030" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC12047489/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40112808/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang,%20Y.%20Q.%20et%20al.%20Practical%20microenvironment%20classification%20in%20diffuse%20large%20B%20cell%20lymphoma%20using%20digital%20pathology.%20Cell%20Rep.%20Med.6,%20102030.%2010.1016/j.xcrm.2025.102030%20(2025)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR9">
<span class="label">9.</span><cite>Taylor, K. H. et al. Aberrant epigenetic gene regulation in lymphoid malignancies. <em>Semin. Hematol.</em><strong>50</strong>, 38–47. 10.1053/j.seminhematol.2013.01.003 (2013).
</cite> [<a href="https://doi.org/10.1053/j.seminhematol.2013.01.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23507482/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Taylor,%20K.%20H.%20et%20al.%20Aberrant%20epigenetic%20gene%20regulation%20in%20lymphoid%20malignancies.%20Semin.%20Hematol.50,%2038%E2%80%9347.%2010.1053/j.seminhematol.2013.01.003%20(2013)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR10">
<span class="label">10.</span><cite>Wright, K. T. et al. Diffuse large B-cell lymphomas have spatially defined, tumor immune microenvironments revealed by high-parameter imaging. <em>Blood Adv.</em><strong>7</strong>, 4633–4646. 10.1182/bloodadvances.2023009813 (2023).
</cite> [<a href="https://doi.org/10.1182/bloodadvances.2023009813" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10448427/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37196647/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wright,%20K.%20T.%20et%20al.%20Diffuse%20large%20B-cell%20lymphomas%20have%20spatially%20defined,%20tumor%20immune%20microenvironments%20revealed%20by%20high-parameter%20imaging.%20Blood%20Adv.7,%204633%E2%80%934646.%2010.1182/bloodadvances.2023009813%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR11">
<span class="label">11.</span><cite>Geanes, E. S. et al. Development of combinatorial antibody therapies for diffuse large B cell lymphoma. <em>Front. Med. (Lausanne)</em><strong>9</strong>, 1034594. 10.3389/fmed.2022.1034594( (2022).
</cite> [<a href="https://doi.org/10.3389/fmed.2022.1034594" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9637670/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36353222/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Geanes,%20E.%20S.%20et%20al.%20Development%20of%20combinatorial%20antibody%20therapies%20for%20diffuse%20large%20B%20cell%20lymphoma.%20Front.%20Med.%20(Lausanne)9,%201034594.%2010.3389/fmed.2022.1034594(%20(2022)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR12">
<span class="label">12.</span><cite>Pennisi, M. et al. Comparing CAR T-cell toxicity grading systems: Application of the ASTCT grading system and implications for management. <em>Blood Adv.</em><strong>4</strong>, 676–686. 10.1182/bloodadvances.2019000952 (2020).
</cite> [<a href="https://doi.org/10.1182/bloodadvances.2019000952" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7042979/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32084260/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Pennisi,%20M.%20et%20al.%20Comparing%20CAR%20T-cell%20toxicity%20grading%20systems:%20Application%20of%20the%20ASTCT%20grading%20system%20and%20implications%20for%20management.%20Blood%20Adv.4,%20676%E2%80%93686.%2010.1182/bloodadvances.2019000952%20(2020)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR13">
<span class="label">13.</span><cite>Liévin, R. et al. Immune reconstitution and evolution of B-cell-stimulating cytokines after R-CHOP therapy for HIV-associated DLBCL. <em>Blood Adv.</em><strong>8</strong>, 6017–6027. 10.1182/bloodadvances.2024014116 (2024).
</cite> [<a href="https://doi.org/10.1182/bloodadvances.2024014116" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11635670/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39348664/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Li%C3%A9vin,%20R.%20et%20al.%20Immune%20reconstitution%20and%20evolution%20of%20B-cell-stimulating%20cytokines%20after%20R-CHOP%20therapy%20for%20HIV-associated%20DLBCL.%20Blood%20Adv.8,%206017%E2%80%936027.%2010.1182/bloodadvances.2024014116%20(2024)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR14">
<span class="label">14.</span><cite>Xu-Monette, Z. Y. et al. DNA mismatch repair defect and intratumor heterogeneous deficiency differently impact immune responses in diffuse large B-cell lymphoma. <em>Oncoimmunology</em><strong>13</strong>, 2384667. 10.1080/2162402x.2024.2384667 (2024).
</cite> [<a href="https://doi.org/10.1080/2162402X.2024.2384667" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11302547/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39108501/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Xu-Monette,%20Z.%20Y.%20et%20al.%20DNA%20mismatch%20repair%20defect%20and%20intratumor%20heterogeneous%20deficiency%20differently%20impact%20immune%20responses%20in%20diffuse%20large%20B-cell%20lymphoma.%20Oncoimmunology13,%202384667.%2010.1080/2162402x.2024.2384667%20(2024)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR15">
<span class="label">15.</span><cite>Ling, H., Li, Y., Wang, P., Zhang, Z. &amp; Yang, Z. Diffuse large B-cell lymphoma cell-derived exosomal NSUN2 stabilizes PDL1 to promote tumor immune escape and M2 macrophage polarization in a YBX1-dependent manner. <em>Arch. Biochem. Biophys.</em><strong>766</strong>, 110322. 10.1016/j.abb.2025.110322 (2025).
</cite> [<a href="https://doi.org/10.1016/j.abb.2025.110322" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39864779/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ling,%20H.,%20Li,%20Y.,%20Wang,%20P.,%20Zhang,%20Z.%20&amp;%20Yang,%20Z.%20Diffuse%20large%20B-cell%20lymphoma%20cell-derived%20exosomal%20NSUN2%20stabilizes%20PDL1%20to%20promote%20tumor%20immune%20escape%20and%20M2%20macrophage%20polarization%20in%20a%20YBX1-dependent%20manner.%20Arch.%20Biochem.%20Biophys.766,%20110322.%2010.1016/j.abb.2025.110322%20(2025)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR16">
<span class="label">16.</span><cite>Shi, Q. et al. Positron emission tomography-adapted therapy in low-risk diffuse large B-cell lymphoma: Results of a randomized, phase III, non-inferiority trial. <em>Cancer Commun. (Lond.)</em><strong>43</strong>, 896–908. 10.1002/cac2.12462 (2023).
</cite> [<a href="https://doi.org/10.1002/cac2.12462" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10397561/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37403255/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Shi,%20Q.%20et%20al.%20Positron%20emission%20tomography-adapted%20therapy%20in%20low-risk%20diffuse%20large%20B-cell%20lymphoma:%20Results%20of%20a%20randomized,%20phase%20III,%20non-inferiority%20trial.%20Cancer%20Commun.%20(Lond.)43,%20896%E2%80%93908.%2010.1002/cac2.12462%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR17">
<span class="label">17.</span><cite>Ma, K. et al. T cell-based cancer immunotherapy: Opportunities and challenges. <em>Sci. Bull. (Beijing)</em>10.1016/j.scib.2025.03.054 (2025).
</cite> [<a href="https://doi.org/10.1016/j.scib.2025.03.054" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40221316/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ma,%20K.%20et%20al.%20T%20cell-based%20cancer%20immunotherapy:%20Opportunities%20and%20challenges.%20Sci.%20Bull.%20(Beijing)10.1016/j.scib.2025.03.054%20(2025)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR18">
<span class="label">18.</span><cite>Huppa, J. B. &amp; Davis, M. M. T-cell-antigen recognition and the immunological synapse. <em>Nat. Rev. Immunol.</em><strong>3</strong>, 973–983. 10.1038/nri1245 (2003).
</cite> [<a href="https://doi.org/10.1038/nri1245" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/14647479/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Huppa,%20J.%20B.%20&amp;%20Davis,%20M.%20M.%20T-cell-antigen%20recognition%20and%20the%20immunological%20synapse.%20Nat.%20Rev.%20Immunol.3,%20973%E2%80%93983.%2010.1038/nri1245%20(2003)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR19">
<span class="label">19.</span><cite>Weiss, A. &amp; Littman, D. R. Signal transduction by lymphocyte antigen receptors. <em>Cell</em><strong>76</strong>, 263–274. 10.1016/0092-8674(94)90334-4 (1994).
</cite> [<a href="https://doi.org/10.1016/0092-8674(94)90334-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8293463/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Weiss,%20A.%20&amp;%20Littman,%20D.%20R.%20Signal%20transduction%20by%20lymphocyte%20antigen%20receptors.%20Cell76,%20263%E2%80%93274.%2010.1016/0092-8674(94)90334-4%20(1994)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR20">
<span class="label">20.</span><cite>Zaemes, J. &amp; Gibney, G. T. Cellular therapy for advanced melanoma. <em>Surg. Clin. North Am.</em><strong>105</strong>, 681–690. 10.1016/j.suc.2025.03.004 (2025).
</cite> [<a href="https://doi.org/10.1016/j.suc.2025.03.004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40412894/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zaemes,%20J.%20&amp;%20Gibney,%20G.%20T.%20Cellular%20therapy%20for%20advanced%20melanoma.%20Surg.%20Clin.%20North%20Am.105,%20681%E2%80%93690.%2010.1016/j.suc.2025.03.004%20(2025)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR21">
<span class="label">21.</span><cite>Crabtree, G. R. &amp; Olson, E. N. NFAT signaling: Choreographing the social lives of cells. <em>Cell</em><strong>109</strong>(Suppl), S67-79. 10.1016/s0092-8674(02)00699-2 (2002).
</cite> [<a href="https://doi.org/10.1016/s0092-8674(02)00699-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11983154/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Crabtree,%20G.%20R.%20&amp;%20Olson,%20E.%20N.%20NFAT%20signaling:%20Choreographing%20the%20social%20lives%20of%20cells.%20Cell109(Suppl),%20S67-79.%2010.1016/s0092-8674(02)00699-2%20(2002)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR22">
<span class="label">22.</span><cite>Anannya, O., Huang, W. &amp; August, A. The kinase ITK controls a Ca<sup>(2+)</sup>-mediated switch that balances T(H)17 and T(reg) cell differentiation. <em>Sci. Signal</em><strong>17</strong>, 2381. 10.1126/scisignal.adh2381 (2024).</cite> [<a href="https://doi.org/10.1126/scisignal.adh2381" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11445781/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39042726/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Anannya,%20O.,%20Huang,%20W.%20&amp;%20August,%20A.%20The%20kinase%20ITK%20controls%20a%20Ca(2+)-mediated%20switch%20that%20balances%20T(H)17%20and%20T(reg)%20cell%20differentiation.%20Sci.%20Signal17,%202381.%2010.1126/scisignal.adh2381%20(2024)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR23">
<span class="label">23.</span><cite>Kanamori, T. et al. CD4<sup>+</sup> and CD8<sup>+</sup> T-lymphocyte number as predictive marker of relapse after rituximab treatment in childhood-onset refractory nephrotic syndrome. <em>Clin. Exp. Nephrol.</em><strong>27</strong>, 622–630. 10.1007/s10157-023-02343-z (2023).
</cite> [<a href="https://doi.org/10.1007/s10157-023-02343-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37095341/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kanamori,%20T.%20et%20al.%20CD4+%20and%20CD8+%20T-lymphocyte%20number%20as%20predictive%20marker%20of%20relapse%20after%20rituximab%20treatment%20in%20childhood-onset%20refractory%20nephrotic%20syndrome.%20Clin.%20Exp.%20Nephrol.27,%20622%E2%80%93630.%2010.1007/s10157-023-02343-z%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR24">
<span class="label">24.</span><cite>Wang, X. et al. Combination of expanded allogeneic NK cells and T cell-based immunotherapy exert enhanced antitumor effects. <em>Cancers (Basel)</em><strong>15</strong>, 251. 10.3390/cancers15010251 (2022).
</cite> [<a href="https://doi.org/10.3390/cancers15010251" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9818244/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36612246/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang,%20X.%20et%20al.%20Combination%20of%20expanded%20allogeneic%20NK%20cells%20and%20T%20cell-based%20immunotherapy%20exert%20enhanced%20antitumor%20effects.%20Cancers%20(Basel)15,%20251.%2010.3390/cancers15010251%20(2022)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR25">
<span class="label">25.</span><cite>Enqvist, M. et al. Systemic and intra-nodal activation of NK cells after rituximab monotherapy for follicular lymphoma. <em>Front. Immunol.</em><strong>10</strong>, 2085. 10.3389/fimmu.2019.02085 (2019).
</cite> [<a href="https://doi.org/10.3389/fimmu.2019.02085" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6751265/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31572357/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Enqvist,%20M.%20et%20al.%20Systemic%20and%20intra-nodal%20activation%20of%20NK%20cells%20after%20rituximab%20monotherapy%20for%20follicular%20lymphoma.%20Front.%20Immunol.10,%202085.%2010.3389/fimmu.2019.02085%20(2019)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR26">
<span class="label">26.</span><cite>Fischer, M. A., Jia, L. &amp; Edelblum, K. L. Type I IFN induces TCR-dependent and -independent antimicrobial responses in γδ Intraepithelial lymphocytes. <em>J. Immunol.</em><strong>213</strong>, 1380–1391. 10.4049/jimmunol.2400138 (2024).
</cite> [<a href="https://doi.org/10.4049/jimmunol.2400138" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11493514/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39311642/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Fischer,%20M.%20A.,%20Jia,%20L.%20&amp;%20Edelblum,%20K.%20L.%20Type%20I%20IFN%20induces%20TCR-dependent%20and%20-independent%20antimicrobial%20responses%20in%20%CE%B3%CE%B4%20Intraepithelial%20lymphocytes.%20J.%20Immunol.213,%201380%E2%80%931391.%2010.4049/jimmunol.2400138%20(2024)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR27">
<span class="label">27.</span><cite>Chen, Y. et al. ARAP1-AS1 overexpression increases diffuse large B cell lymphoma progression by sponging miR-508-5p to activate the EMP1-PI3K/AKT pathway. <em>Hematol. Oncol.</em><strong>43</strong>, e70056. 10.1002/hon.70056 (2025).
</cite> [<a href="https://doi.org/10.1002/hon.70056" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40227114/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chen,%20Y.%20et%20al.%20ARAP1-AS1%20overexpression%20increases%20diffuse%20large%20B%20cell%20lymphoma%20progression%20by%20sponging%20miR-508-5p%20to%20activate%20the%20EMP1-PI3K/AKT%20pathway.%20Hematol.%20Oncol.43,%20e70056.%2010.1002/hon.70056%20(2025)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR28">
<span class="label">28.</span><cite>Banchi, M. et al. Synergistic activity of tafasitamab and metronomic chemotherapy on diffuse large B-cell lymphoma through inhibition of the AKT/mTOR signaling pathway. <em>Sci. Rep.</em><strong>15</strong>, 11372. 10.1038/s41598-025-95476-y (2025).
</cite> [<a href="https://doi.org/10.1038/s41598-025-95476-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11965395/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40175588/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Banchi,%20M.%20et%20al.%20Synergistic%20activity%20of%20tafasitamab%20and%20metronomic%20chemotherapy%20on%20diffuse%20large%20B-cell%20lymphoma%20through%20inhibition%20of%20the%20AKT/mTOR%20signaling%20pathway.%20Sci.%20Rep.15,%2011372.%2010.1038/s41598-025-95476-y%20(2025)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR29">
<span class="label">29.</span><cite>Liang, Y. et al. Dose-adjusted EPOCH-R vs. R-CHOP in frontline management of Waldeyer’s ring diffuse large B-cell lymphoma: A retrospective study from a single institution. <em>Chin. Med. J. (Engl.)</em><strong>136</strong>, 167–175. 10.1097/cm9.0000000000002593 (2023).
</cite> [<a href="https://doi.org/10.1097/CM9.0000000000002593" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10106141/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36780421/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Liang,%20Y.%20et%20al.%20Dose-adjusted%20EPOCH-R%20vs.%20R-CHOP%20in%20frontline%20management%20of%20Waldeyer%E2%80%99s%20ring%20diffuse%20large%20B-cell%20lymphoma:%20A%20retrospective%20study%20from%20a%20single%20institution.%20Chin.%20Med.%20J.%20(Engl.)136,%20167%E2%80%93175.%2010.1097/cm9.0000000000002593%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR30">
<span class="label">30.</span><cite>Cassidy, R. J. et al. The role of radiotherapy for patients over age 60 with diffuse large B-cell lymphoma in the rituximab era. <em>Leuk Lymphoma</em><strong>57</strong>, 1876–1882. 10.3109/10428194.2015.1120866 (2016).
</cite> [<a href="https://doi.org/10.3109/10428194.2015.1120866" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4949106/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26759182/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cassidy,%20R.%20J.%20et%20al.%20The%20role%20of%20radiotherapy%20for%20patients%20over%20age%2060%20with%20diffuse%20large%20B-cell%20lymphoma%20in%20the%20rituximab%20era.%20Leuk%20Lymphoma57,%201876%E2%80%931882.%2010.3109/10428194.2015.1120866%20(2016)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR31">
<span class="label">31.</span><cite>Kanehisa, M., Furumichi, M., Sato, Y., Matsuura, Y. &amp; Ishiguro-Watanabe, M. KEGG: Biological systems database as a model of the real world. <em>Nucleic Acids Res.</em><strong>53</strong>, D672-d677. 10.1093/nar/gkae909 (2025).
</cite> [<a href="https://doi.org/10.1093/nar/gkae909" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11701520/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39417505/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kanehisa,%20M.,%20Furumichi,%20M.,%20Sato,%20Y.,%20Matsuura,%20Y.%20&amp;%20Ishiguro-Watanabe,%20M.%20KEGG:%20Biological%20systems%20database%20as%20a%20model%20of%20the%20real%20world.%20Nucleic%20Acids%20Res.53,%20D672-d677.%2010.1093/nar/gkae909%20(2025)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR32">
<span class="label">32.</span><cite>Kanehisa, M. Toward understanding the origin and evolution of cellular organisms. <em>Protein Sci.</em><strong>28</strong>, 1947–1951. 10.1002/pro.3715 (2019).
</cite> [<a href="https://doi.org/10.1002/pro.3715" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6798127/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31441146/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kanehisa,%20M.%20Toward%20understanding%20the%20origin%20and%20evolution%20of%20cellular%20organisms.%20Protein%20Sci.28,%201947%E2%80%931951.%2010.1002/pro.3715%20(2019)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR33">
<span class="label">33.</span><cite>Kanehisa, M. &amp; Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. <em>Nucleic Acids Res.</em><strong>28</strong>, 27–30. 10.1093/nar/28.1.27 (2000).
</cite> [<a href="https://doi.org/10.1093/nar/28.1.27" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC102409/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10592173/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kanehisa,%20M.%20&amp;%20Goto,%20S.%20KEGG:%20Kyoto%20encyclopedia%20of%20genes%20and%20genomes.%20Nucleic%20Acids%20Res.28,%2027%E2%80%9330.%2010.1093/nar/28.1.27%20(2000)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR34">
<span class="label">34.</span><cite>Uddin, M. N. &amp; Thomas, D. W. T lymphocyte integrated endoplasmic reticulum Ca<sup>(2+)</sup> store signaling functions are linked to sarco/endoplasmic reticulum Ca<sup>(2+)</sup>-ATPase isoform-specific levels of regulation. <em>Int. J. Mol. Sci.</em><strong>26</strong>, 4147. 10.3390/ijms26094147 (2025).
</cite> [<a href="https://doi.org/10.3390/ijms26094147" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC12071366/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40362384/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Uddin,%20M.%20N.%20&amp;%20Thomas,%20D.%20W.%20T%20lymphocyte%20integrated%20endoplasmic%20reticulum%20Ca(2+)%20store%20signaling%20functions%20are%20linked%20to%20sarco/endoplasmic%20reticulum%20Ca(2+)-ATPase%20isoform-specific%20levels%20of%20regulation.%20Int.%20J.%20Mol.%20Sci.26,%204147.%2010.3390/ijms26094147%20(2025)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR35">
<span class="label">35.</span><cite>Sheriff, L. et al. Lag3 and PD-1 pathways preferentially regulate NFAT-dependent TCR signalling programmes during early CD<sub>4</sub><sup>(+)</sup> T cell activation. <em>Immunother. Adv.</em><strong>5</strong>, 015. 10.1093/immadv/ltaf015 (2025).</cite> [<a href="https://doi.org/10.1093/immadv/ltaf015" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC12066006/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40351814/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sheriff,%20L.%20et%20al.%20Lag3%20and%20PD-1%20pathways%20preferentially%20regulate%20NFAT-dependent%20TCR%20signalling%20programmes%20during%20early%20CD4(+)%20T%20cell%20activation.%20Immunother.%20Adv.5,%20015.%2010.1093/immadv/ltaf015%20(2025)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR36">
<span class="label">36.</span><cite>Guichard, V. et al. Pre-existing epigenetic state and differential NF-κB activation shape type 2 immune cell responses. <em>Immunity</em>10.1016/j.immuni.2025.04.016 (2025).
</cite> [<a href="https://doi.org/10.1016/j.immuni.2025.04.016" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40367949/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Guichard,%20V.%20et%20al.%20Pre-existing%20epigenetic%20state%20and%20differential%20NF-%CE%BAB%20activation%20shape%20type%202%20immune%20cell%20responses.%20Immunity10.1016/j.immuni.2025.04.016%20(2025)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR37">
<span class="label">37.</span><cite>Räuber, S. et al. Flow cytometry identifies changes in peripheral and intrathecal lymphocyte patterns in CNS autoimmune disorders and primary CNS malignancies. <em>J. Neuroinflamm.</em><strong>21</strong>, 286. 10.1186/s12974-024-03269-3 (2024).</cite> [<a href="https://doi.org/10.1186/s12974-024-03269-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11536547/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39497174/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?R%C3%A4uber,%20S.%20et%20al.%20Flow%20cytometry%20identifies%20changes%20in%20peripheral%20and%20intrathecal%20lymphocyte%20patterns%20in%20CNS%20autoimmune%20disorders%20and%20primary%20CNS%20malignancies.%20J.%20Neuroinflamm.21,%20286.%2010.1186/s12974-024-03269-3%20(2024)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR38">
<span class="label">38.</span><cite>Sui, Y. et al. Rupatadine-inhibited OTUD3 promotes DLBCL progression and immune evasion through deubiquitinating MYL12A and PD-L1. <em>Cell Death Dis.</em><strong>15</strong>, 561. 10.1038/s41419-024-06941-x (2024).
</cite> [<a href="https://doi.org/10.1038/s41419-024-06941-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11297949/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39097608/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sui,%20Y.%20et%20al.%20Rupatadine-inhibited%20OTUD3%20promotes%20DLBCL%20progression%20and%20immune%20evasion%20through%20deubiquitinating%20MYL12A%20and%20PD-L1.%20Cell%20Death%20Dis.15,%20561.%2010.1038/s41419-024-06941-x%20(2024)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR39">
<span class="label">39.</span><cite>Coënon, L. &amp; Villalba, M. From CD16a biology to antibody-dependent cell-mediated cytotoxicity improvement. <em>Front. Immunol.</em><strong>13</strong>, 913215. 10.3389/fimmu.2022.913215 (2022).
</cite> [<a href="https://doi.org/10.3389/fimmu.2022.913215" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9203678/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35720368/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Co%C3%ABnon,%20L.%20&amp;%20Villalba,%20M.%20From%20CD16a%20biology%20to%20antibody-dependent%20cell-mediated%20cytotoxicity%20improvement.%20Front.%20Immunol.13,%20913215.%2010.3389/fimmu.2022.913215%20(2022)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR40">
<span class="label">40.</span><cite>Chin, D. S., Lim, C. S. Y., Nordin, F., Arifin, N. &amp; Jun, T. G. Antibody-dependent cell-mediated cytotoxicity through natural killer (NK) cells: Unlocking NK cells for future immunotherapy. <em>Curr. Pharm. Biotechnol.</em><strong>23</strong>, 552–578. 10.2174/1389201022666210820093608 (2022).
</cite> [<a href="https://doi.org/10.2174/1389201022666210820093608" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34414871/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chin,%20D.%20S.,%20Lim,%20C.%20S.%20Y.,%20Nordin,%20F.,%20Arifin,%20N.%20&amp;%20Jun,%20T.%20G.%20Antibody-dependent%20cell-mediated%20cytotoxicity%20through%20natural%20killer%20(NK)%20cells:%20Unlocking%20NK%20cells%20for%20future%20immunotherapy.%20Curr.%20Pharm.%20Biotechnol.23,%20552%E2%80%93578.%2010.2174/1389201022666210820093608%20(2022)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR41">
<span class="label">41.</span><cite>Vincken, R., Armendáriz-Martínez, U. &amp; Ruiz-Sáenz, A. ADCC: The rock band led by therapeutic antibodies, tumor and immune cells. <em>Front. Immunol.</em><strong>16</strong>, 1548292. 10.3389/fimmu.2025.1548292 (2025).
</cite> [<a href="https://doi.org/10.3389/fimmu.2025.1548292" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC12040827/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40308580/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Vincken,%20R.,%20Armend%C3%A1riz-Mart%C3%ADnez,%20U.%20&amp;%20Ruiz-S%C3%A1enz,%20A.%20ADCC:%20The%20rock%20band%20led%20by%20therapeutic%20antibodies,%20tumor%20and%20immune%20cells.%20Front.%20Immunol.16,%201548292.%2010.3389/fimmu.2025.1548292%20(2025)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR42">
<span class="label">42.</span><cite>Lee, S. C., Srivastava, R. M., López-Albaitero, A., Ferrone, S. &amp; Ferris, R. L. Natural killer (NK): Dendritic cell (DC) cross talk induced by therapeutic monoclonal antibody triggers tumor antigen-specific T cell immunity. <em>Immunol. Res.</em><strong>50</strong>, 248–254. 10.1007/s12026-011-8231-0 (2011).
</cite> [<a href="https://doi.org/10.1007/s12026-011-8231-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3415245/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21717064/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lee,%20S.%20C.,%20Srivastava,%20R.%20M.,%20L%C3%B3pez-Albaitero,%20A.,%20Ferrone,%20S.%20&amp;%20Ferris,%20R.%20L.%20Natural%20killer%20(NK):%20Dendritic%20cell%20(DC)%20cross%20talk%20induced%20by%20therapeutic%20monoclonal%20antibody%20triggers%20tumor%20antigen-specific%20T%20cell%20immunity.%20Immunol.%20Res.50,%20248%E2%80%93254.%2010.1007/s12026-011-8231-0%20(2011)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR43">
<span class="label">43.</span><cite>Lue, J. K. &amp; O’Connor, O. A. A perspective on improving the R-CHOP regimen: From Mega-CHOP to ROBUST R-CHOP, the PHOENIX is yet to rise. <em>Lancet Haematol.</em><strong>7</strong>, e838–e850. 10.1016/s2352-3026(20)30222-2 (2020).
</cite> [<a href="https://doi.org/10.1016/S2352-3026(20)30222-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33091357/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lue,%20J.%20K.%20&amp;%20O%E2%80%99Connor,%20O.%20A.%20A%20perspective%20on%20improving%20the%20R-CHOP%20regimen:%20From%20Mega-CHOP%20to%20ROBUST%20R-CHOP,%20the%20PHOENIX%20is%20yet%20to%20rise.%20Lancet%20Haematol.7,%20e838%E2%80%93e850.%2010.1016/s2352-3026(20)30222-2%20(2020)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12371038/bin/41598_2025_16112_MOESM1_ESM.docx" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Information.</a><sup> (513.4KB, docx) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>Data is provided within the manuscript or supplementary information files.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Scientific Reports are provided here courtesy of <strong>Nature Publishing Group</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1038/s41598-025-16112-3"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/41598_2025_Article_16112.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (8.6 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12371038/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12371038/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12371038%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12371038/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12371038/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12371038/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40841435/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12371038/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40841435/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12371038/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12371038/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="iBKxXbR9FaUVaUYOqg9Cu1TdoGGfrs7IItMwOjhI6d6nZB0GWJk8nID8Fjd5OqM5">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
